WO2004064618A2 - Methods for making oxidation resistant polymeric material - Google Patents
Methods for making oxidation resistant polymeric material Download PDFInfo
- Publication number
- WO2004064618A2 WO2004064618A2 PCT/US2004/000857 US2004000857W WO2004064618A2 WO 2004064618 A2 WO2004064618 A2 WO 2004064618A2 US 2004000857 W US2004000857 W US 2004000857W WO 2004064618 A2 WO2004064618 A2 WO 2004064618A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymeric material
- medical implant
- antioxidant
- cross
- forming
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
- B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
- B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
- B29C35/0805—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/505—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/143—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/143—Stabilizers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/003—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor characterised by the choice of material
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/28—Treatment by wave energy or particle radiation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/005—Stabilisers against oxidation, heat, light, ozone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/15—Heterocyclic compounds having oxygen in the ring
- C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
- C08K5/1545—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/06—Polyethene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2312/00—Crosslinking
- C08L2312/06—Crosslinking by radiation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49995—Shaping one-piece blank by removing material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31855—Of addition polymer from unsaturated monomers
Definitions
- the present invention relates to methods for making oxidation resistant medical devices that comprise polymeric materials. Methods of doping polyethylene with an antioxidant, for example, vitamin E, and materials used therewith also are provided.
- Oxidation resistant cross-linked polymeric material such as ultra-high molecular weight polyethylene (UHMWPE)
- UHMWPE ultra-high molecular weight polyethylene
- the preferred method of crosslinking is by exposing the UHMWPE to ionizing radiation.
- ionizing radiation in addition to crosslinking, also will generate residual free radicals, which are the precursors of oxidation-induced embrittlement. Melting after irradiation is used to eliminate the crystals and allow the residual free radicals to recombine with each other. The irradiation with subsequent melting is used to reduce the potential for oxidation secondary to the residual free radicals.
- the addition of the antioxidant to the UHMWPE prior to irradiation can inhibit crosslinking of the UHMWPE during irradiation.
- crosslinking is needed to increase the wear resistance of the polymer. Therefore, it would be preferable to have a medical implant, or any polymeric component thereof, doped with an antioxidant in its consolidated solid form, such as feed-stock, machined components, or molded components.
- this was not possible with prior art practices.
- the present invention relates generally to methods of making oxidation resistant medical devices that comprises one or more polymeric materials. More specifically, the invention relates to methods of manufacturing antioxidant doped medical devices containing cross-linked polyethylene, for example, cross-linked ultra-high molecular weight polyethylene (UHMWPE), and materials used therein. More specifically, the invention relates to methods of manufacturing antioxidant-doped, non-oxidizing medical device containing cross-linked polyethylene with residual free radicals, for example, irradiated ultra-high molecular weight polyethylene (UHMWPE) and materials used therein.
- UHMWPE cross-linked ultra-high molecular weight polyethylene
- the invention provides methods of making cross-linked polymeric material comprising the steps of: a) providing consolidated and cross-linked polymeric material that has been irradiated with ionizing radiation; and b) doping the consolidated and cross-linked polymeric material with an antioxidant by diffusion.
- the invention provides methods of making cross-linked polymeric material comprising the steps of: a) providing consolidated and cross-linked polymeric material that has been irradiated with ionizing radiation; b) doping the consolidated and cross-linked polymeric material with an antioxidant by diffusion; and c) heating the consolidated and cross-linked polymeric material to a temperature below the melting point of the consolidated and cross-linked polymeric material.
- the invention provides methods of making cross-linked polymeric material, wherein the cross-linked polymeric material is soaked in a solution, of about 50%) by weight, of an antioxidant in an alcohol, such as ethanol, wherein the cross-linked polymeric material is diffused with the antioxidant in a supercritical fluid, such as CO 2 .
- the invention provides methods of making cross-linked polymeric material comprising the steps of: a) placing a consolidated and cross-linked polymeric material in a pressure chamber; b) filling the chamber with an antioxidant, either in a neat form (about 100%) or in a solution such as a 50%o mixture of the antioxidant and alcohol, such as ethanol; and c) pressurizing the chamber to enhance diffusion of the antioxidant into the consolidated and cross-linked polymeric material.
- the invention provides methods of making cross-linked polymeric material comprising the steps of: a) doping the consolidated polymeric material with an antioxidant by diffusion; b) irradiating the consolidated polymeric material with ionizing radiation, thereby forming a consolidated and cross-linked polymeric material; and c) annealing the consolidated and cross-linked polymeric material at a temperature below or above melt of the consolidated and cross-linked polymeric material.
- the invention provides methods of making cross- linked polymeric material, comprising the steps of: a) consolidating a polymeric material; b) irradiating the polymeric material with ionizing radiation, thereby forming a consolidated and cross-linked polymeric material; c) doping the consolidated and cross- linked polymeric material with an antioxidant by diffusion; and d) heating the consolidated and cross-linked polymeric material at a temperature below the melting point of the consolidated and cross-linked polymeric material.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) irradiating the consolidated polymeric material with ionizing radiation, thereby forming a consolidated and cross-linked polymeric material; d) machining the consolidated and cross-linked polymeric material, thereby forming a medical implant; and e) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant-doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) irradiating the consolidated polymeric material with ionizing radiation, thereby forming a consolidated and cross-linked polymeric material; c) machining the consolidated and cross-linked polymeric material, thereby forming a medical implant; and d) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant-doped cross- linked medical implant.
- the invention provides methods of making a medical implant containing antioxidant-doped cross-linked polymeric material comprising: a) irradiating a consolidated polymeric material with ionizing radiation, thereby forming a cross-linked polymeric material; b) machining the consolidated and cross-linked polymeric material, thereby forming a medical implant; and c) doping the medical implant with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing antioxidant-doped cross-linked polymeric material comprising: a) machining a consolidated polymeric material, thereby forming a medical implant; b) doping the medical implant with an antioxidant by diffusion; and c) irradiating the medical implant, thereby forming a medical implant containing cross-linked polymeric material.
- the invention provides methods of making a medical implant containing polymeric material comprising: a) irradiating the polymeric material with ionizing radiation, thereby forming a cross-linked polymeric material; and b) doping the cross-linked polymeric material with an antioxidant by diffusion, wherein the cross- linked polymeric material is annealed at a temperature below the melt or above the melt of the consolidated and cross-linked polymeric material.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) compression molding of polymeric material to another piece, thereby forming an interface and an interlocked hybrid material; b) irradiating the interlocked hybrid material by ionizing radiation, thereby forming a cross-linked and interlocked hybrid material; and c) doping the cross- linked and interlocked hybrid material with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) compression molding of polymeric material to another piece, thereby forming an interface and an interlocked hybrid material; b) doping the interlocked hybrid material with an antioxidant by diffusion; and c) irradiating the interlocked hybrid material by ionizing radiation, thereby fo ⁇ ning a cross-linked and interlocked hybrid material.
- the invention provides methods of making a sterile medical implant containing cross-linked polymeric material comprising: a) direct compression molding a polymeric material, thereby forming a medical implant; b) irradiating the medical implant to crosslink the polymeric material; c) doping the irradiated medical implant with an antioxidant by diffusion; d) packaging the irradiated and antioxidant- doped medical implant; and e) sterilizing the packaged irradiated and antioxidant-doped medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a sterile medical implant containing antioxidant doped cross-linked polymeric material comprising: a) machining a consolidated polymeric material, thereby forming a medical implant; b) irradiating the medical implant, thereby forming a medical implant containing cross- linked polymeric material; c) doping the medical implant with an antioxidant by diffusion; d) packaging the irradiated and antioxidant-doped medical implant; and e) sterilizing the packaged medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) doping a polymeric material with an antioxidant by diffusion; b) compression molding of the polymeric material to another piece, thereby forming an interface and an interlocked hybrid material; and c) irradiating the interlocked hybrid material by ionizing radiation, thereby forming a cross- linked and interlocked hybrid material.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) direct compression molding of the polymeric material, thereby forming a medical implant; b) irradiating the medical implant by ionizing radiation, thereby forming a consolidated and cross-linked medical implant; and c) doping the consolidated and cross-linked medical implant with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing antioxidant-doped cross-linked polymeric material comprising: a) machining a consolidated polymeric material, thereby forming a medical implant; b) irradiating the medical implant, thereby forming a medical implant containing cross-linked polymeric material; and c) doping the medical implant with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) direct compression molding polymeric material, thereby forming a medical implant; b) doping the medical implant with an antioxidant by diffusion; c) packaging the medical implant; and d) irradiating the packaged medical implant by ionizing radiation, thereby forming a consolidated and cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) machining a consolidated polymeric material, thereby forming a medical implant; b) doping the medical implant with an antioxidant by diffusion; c) packaging the medical implant; and d) irradiating the packaged medical implant by ionizing radiation, thereby forming a consolidated and cross-linked and sterile medical implant.
- the invention provides methods of making cross-linked polymeric material comprising the steps of: a) placing a consolidated and cross-linked polymeric material in a pressure chamber; b) filling the chamber with an antioxidant; and c) pressurizing the chamber to enhance diffusion of the antioxidant into the consolidated and cross-linked polymeric material.
- the invention provides methods of making medical devices containing cross-linked polymeric material comprising: a) irradiating a manufactured medical device consisting of consolidated polymeric material with ionizing radiation, thereby forming a consolidated and cross-linked polymeric material; and b) doping the consolidated and cross-linked polymeric material with an antioxidant by diffusion, thereby forming an antioxidant-doped consolidated and cross-linked polymeric material.
- the invention provides methods of making a packaging for medical devices that is resistant to oxidation, when subjected to either sterilization or crosslinking doses of ionizing radiation, comprising: a) doping the packaging material with an antioxidant by diffusion; b) inserting a medical device in the packaging material; c) sealing the packaging material containing the medical device, thereby fonning a packaged medical device; and d) irradiating the packaged medical device with ionizing radiation or gas sterilization.
- the invention provides methods of making a packaging for pharmaceutical compounds that is resistant to oxidation, when subjected to either sterilization or crosslinking doses of ionizing radiation, comprising: a) doping the packaging material with an antioxidant by diffusion; b) inserting a pharmaceutical compound in the packaging material; c) sealing the packaging material containing the pharmaceutical compound, thereby forming a packaged pharmaceutical , compound; and d) irradiating the packaged pharmaceutical compound with ionizing radiation or gas sterilization.
- the invention provides methods of making a medical implant containing cross-linked polymeric material, wherein the implant comprises medical devices, including acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, heart valves, tendons, stents, and vascular grafts, wherein the polymeric material is polymeric resin powder, polymeric flakes, polymeric particles, or the like, or a mixture thereof.
- the implant comprises medical devices, including acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, heart valves, tendons, stent
- the invention provides methods of making medical implants, including non-permanent implants, containing cross-linked polymeric material, wherein the implant comprises medical device, including balloon catheters, sutures, tubing, and intravenous tubing, wherein the polymeric material is polymeric resin powder, polymeric flakes, polymeric particles, or the like, or a mixture thereof.
- the polymeric balloons for example, polyether-block co-polyamide polymer (PeBAX®), Nylon, and polyethylene terephthalate (PET) balloons are doped with vitamin E and irradiated before, during, or after doping.
- the invention provides methods of making a packaging for a medical device, wherein the packaging is resistant to oxidation when subjected to sterilization with ionizing radiation or gas sterilization.
- the packaging include barrier materials, for example, blow-molded blister packs, heat-shrinkable packaging, thermally- sealed packaging, or the like or a mixture thereof.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) doping the consolidated polymeric material with an antioxidant by diffusion; and b) irradiating the polymeric material with ionizing radiation, thereby forming a consolidated and cross-linked polymeric material.
- antioxidant-doped medical implants are packaged and sterilized by ionizing radiation or gas sterilization to obtain sterile and cross-linked medical implants.
- the polymeric material of the instant invention is a polymeric resin powder, polymeric flakes, polymeric particles, or the like, or a mixture thereof, wherein the irradiation can be carried out in an atmosphere containing between about 1% and about 22% oxygen, wherein the radiation dose is between about 25 kGy and about lOOO kGy.
- the polymeric material of the instant invention is polymeric resin powder, polymeric flakes, polymeric particles, or the like, or a mixture thereof, wherein the polymeric material is irradiated after consolidation in an inert atmosphere containing a gas, for example, nitrogen, argon, helium, neon, or the like, or a combination thereof, wherein the radiation dose is between about 25 kGy and about 1000 kGy.
- a gas for example, nitrogen, argon, helium, neon, or the like, or a combination thereof, wherein the radiation dose is between about 25 kGy and about 1000 kGy.
- the polymeric material of the instant invention is consolidated polymeric material, where the consolidation can be carried out by compression molding to form a slab from which a medical device is machined.
- the polymeric material of the instant invention is consolidated polymeric material, where the consolidation can be carried out by direct compression molding to form a finished medical device.
- the polymeric material of the instant invention is consolidated polymeric material, where the consolidation can be carried out by compression molding to another piece to form an interface and an interlocked hybrid material.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) compression molding of polymeric material to another piece, thereby forming an interface and an interlocked hybrid material; b) irradiating the interlocked hybrid material by ionizing radiation, thereby forming a cross-linked and interlocked hybrid material; and c) doping the cross- linked and interlocked hybrid material with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising compression molding of polymeric material to another piece, such as a metallic or a non metallic piece, for example, a metal, a ceramic, or a polymer, thereby forming an interface and an interlocked hybrid material, wherein the interface is a metal-polymer or a metal-ceramic interface.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) compression molding of polymeric material to another piece, thereby forming an interface and an interlocked hybrid material; b) doping the interlocked hybrid material with an antioxidant, for example, an ⁇ -tocopherol, such as vitamin E, by diffusion; and c) irradiating the interlocked hybrid material by ionizing radiation, thereby forming a cross- linked and interlocked hybrid material.
- an antioxidant for example, an ⁇ -tocopherol, such as vitamin E
- Another aspect of the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) compression molding a polymeric material, thereby forming a medical implant; b) irradiating the medical implant to crosslink the polymeric material; c) doping the irradiated medical implant with an antioxidant by diffusion; d) packaging the irradiated and antioxidant-doped medical implant; and e) sterilizing the packaged irradiated and antioxidant-doped medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) machining a consolidated polymeric material, thereby forming a medical implant; b) irradiating the medical implant to crosslink the polymeric material; c) doping the irradiated medical implant with an antioxidant by diffusion; d) packaging the irradiated and antioxidant- doped medical implant; and e) sterilizing the packaged irradiated and antioxidant-doped medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) compression molding of polymeric material to another piece, thereby forming an interface and an interlocked hybrid material; b) doping the interlocked hybrid material with an antioxidant by diffusion; and c) irradiating the interlocked hybrid material by ionizing radiation, thereby forming a cross-linked and interlocked hybrid material.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) direct compression molding of the polymeric material, thereby forming a medical implant; b) irradiating the medical implant by ionizing radiation, thereby forming a consolidated and cross-linked medical implant; and c) doping the consolidated and cross-linked medical implant with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) machining a consolidated polymeric material, thereby forming a medical implant; b) irradiating the medical implant by ionizing radiation, thereby forming a consolidated and cross-linked medical implant; and c) doping the consolidated and cross-linked medical implant an antioxidant by diffusion.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) doping the consolidated polymeric material with an antioxidant by diffusion; d) irradiating the antioxidant doped polymeric material by ionizing radiation, thereby forming an antioxidant doped cross-linked polymeric material; and e) machining the cross-linked polymeric material, thereby forming an antioxidant doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) doping the consolidated polymeric material with an antioxidant by diffusion; c) irradiating the antioxidant doped polymeric material by ionizing radiation, thereby forming an antioxidant doped cross- linked polymeric material; and d) machining the cross-linked polymeric material, thereby forming an antioxidant doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) doping the consolidated polymeric material with an antioxidant by diffusion; d) machining the antioxidant doped polymeric material, thereby forming an antioxidant doped polymeric material; and e) irradiating the antioxidant doped cross-linked polymeric material by ionizing radiation, thereby forming an antioxidant doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) doping the consolidated polymeric material with an antioxidant by diffusion; c) machining the antioxidant doped polymeric material, thereby forming an antioxidant doped polymeric material; and d) irradiating the antioxidant doped cross-linked polymeric material by ionizing radiation, thereby forming an antioxidant doped cross-linked medical implant.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) direct compression molding polymeric material, thereby forming a medical implant; b) doping the medical implant an antioxidant by diffusion; c) packaging the medical implant; and d) irradiating the packaged medical implant by ionizing radiation, thereby forming a consolidated and cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) machining the consolidated polymeric material, thereby fo ⁇ ning a medical implant; d) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant doped medical implant; e) packaging the medical implant; and f) irradiating the packaged medical implant by ionizing radiation, thereby forming an antioxidant doped cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) machining the consolidated polymeric material, thereby forming a medical implant; c) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant doped medical implant; d) packaging the medical implant; and e) irradiating the packaged medical implant by ionizing radiation, thereby forming an antioxidant doped cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) doping the consolidated polymeric material with an antioxidant by diffusion, thereby forming an antioxidant doped polymeric material; d) machining the antioxidant-doped polymeric material, thereby forming a medical implant; e) packaging the medical implant; and f) irradiating the packaged medical implant by ionizing radiation, thereby forming an antioxidant doped cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) doping the consolidated polymeric material with an antioxidant by diffusion, thereby forming an antioxidant doped polymeric material; c) machining the antioxidant-doped polymeric material, thereby forming a medical implant; d) packaging the medical implant; and e) irradiating the packaged medical implant by ionizing radiation, thereby forming an antioxidant doped cross-linked and sterile medical implant.
- the invention provides methods of making a sterile medical implant containing antioxidant doped cross-linked polymeric material comprising: a) irradiating a consolidated polymeric material, thereby forming a cross-linked polymeric material; b) machining the consolidated and cross-linked polymeric material, thereby forming a medical implant; c) doping the medical implant with an antioxidant by diffusion; d) packaging the irradiated and antioxidant-doped medical implant; and e) sterilizing the packaged medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a sterile medical implant containing antioxidant doped cross-linked polymeric material comprising: a) doping a polymeric material with an antioxidant; b) consolidating the antioxidant-doped polymeric material; c) machining the consolidated antioxidant-doped polymeric material, thereby forming an antioxidant-doped medical implant; d) irradiating the medical implant, thereby forming a medical implant containing antioxidant-doped cross-linked polymeric material; e) packaging the antioxidant-doped cross-linked medical implant; and f) sterilizing the packaged medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a sterile medical implant containing antioxidant doped cross-linked polymeric material comprising: a) doping a polymeric material with an antioxidant; b) consolidating the antioxidant-doped polymeric material; c) irradiating the consolidated polymeric material, thereby forming an antioxidant-doped cross-linked polymeric material; d) machining the consolidated and cross-linked polymeric material, thereby forming a medical implant containing an antioxidant-doped cross-linked polymeric material; e) packaging the antioxidant-doped cross-linked medical implant; and f) sterilizing the packaged medical implant by ionizing radiation or gas sterilization, thereby forming a cross-linked and sterile medical implant.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) doping a polymeric material with an antioxidant by diffusion; b) irradiating the antioxidant-doped polymeric material by ionizing radiation, thereby forming a cross-linked antioxidant-doped polymeric material; and c) compression molding of the cross-linked antioxidant-doped polymeric material to another piece, thereby forming a cross-linked and interlocked hybrid material.
- the invention provides methods of making a medical implant containing cross-linked polymeric material comprising: a) irradiating a consolidated polymeric material by ionizing radiation, thereby forming a consolidated and cross-linked polymeric material; b) direct compression molding of the polymeric material, thereby forming a consolidated and cross-linked medical implant; and c) doping the consolidated and cross-linked medical implant with an antioxidant by diffusion.
- the invention provides methods of making a medical implant containing antioxidant doped cross-linked polymeric material comprising: a) doping a polymeric material with an antioxidant; b) consolidating the antioxidant-doped polymeric material; c) machining the consolidated antioxidant-doped polymeric material, thereby forming an antioxidant-doped medical implant; and d) irradiating the medical implant, thereby forming a medical implant containing antioxidant-doped cross-linked polymeric material.
- the invention provides methods of making a medical implant containing antioxidant doped cross-linked polymeric material comprising: a) doping a polymeric material with an antioxidant; b) consolidating the antioxidant-doped polymeric material; c) irradiating the consolidated polymeric material, thereby forming an antioxidant-doped cross-linked polymeric material; and d) machining the consolidated and cross-linked polymeric material, thereby forming a medical implant containing an antioxidant-doped cross-linked polymeric material.
- the invention provides methods of making a non-permanent medical device containing cross-linked polymeric material comprising: a) doping a manufactured medical device containing consolidated polymeric material with an antioxidant by diffusion, thereby forming an antioxidant-doped polymeric material; and b) irradiating the medical device with ionizing radiation, thereby forming a cross-linked polymeric material.
- the invention provides non-oxidizing cross-linked polymeric materials with detectable residual free radicals.
- the invention provides non-oxidizing cross-linked medical implants, including permanent and non-permanent medical devices, with detectable residual free radicals.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) machining the consolidated polymeric material, thereby forming a medical implant; d), irradiating the medical implant with ionizing radiation, thereby forming a cross-linked medical implant; and e) doping the medical implant with an antioxidant by diffusion, thereby fo ⁇ ning an antioxidant-doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) machining the consolidated polymeric material, thereby forming a medical implant; c) irradiating the medical implant with ionizing radiation, thereby forming an antioxidant-doped cross- linked medical implant; and d) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant-doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) machining the consolidated polymeric material, thereby forming a medical implant; d) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant-doped medical implant; and e) inadiating the medical implant with ionizing radiation, thereby forming an antioxidant-doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) machining the consolidated polymeric material, thereby forming a medical implant; c) doping the medical implant with an antioxidant by diffusion, thereby forming an antioxidant-doped medical implant; and d) irradiating the medical implant with ionizing radiation, thereby forming an antioxidant-doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) consolidating the polymeric material; c) irradiating the polymeric material with ionizing radiation, thereby forming a cross- linked polymeric material; d) doping the polymeric material with an antioxidant by diffusion, thereby forming an antioxidant-doped cross-linked polymeric material; and e) machining the polymeric material, thereby forming an antioxidant-doped cross-linked medical implant.
- the invention provides methods of making a medical implant comprising: a) providing a consolidated polymeric material; b) irradiating the polymeric material with ionizing radiation, thereby forming a cross-linked polymeric material; c) doping the polymeric material with an antioxidant by diffusion, thereby forming an antioxidant-doped cross-linked polymeric material; and d) machining the polymeric material, thereby forming an antioxidant-doped cross-linked medical implant.
- Another aspect of the invention provides methods of making a medical implant comprising: a) providing a polymeric material; b) compression molding the polymeric material, thereby forming a medical implant; c) doping the medical implant containing an interface or an interlocked hybrid material with an antioxidant by diffusion, thereby forming an antioxidant-doped medical implant; d) packaging the medical implant; and e) irradiating the packaged medical implant by ionizing radiation, thereby forming an antioxidant-doped cross-linked and sterile medical implant.
- the polymeric material is compression molded to another piece or a medical implant, thereby form an interface or an interlocked hybrid material.
- Another aspect of the invention provides methods of making a medical implant comprising: a) providing a compression molded polymeric material forming a medical implant; b) doping the medical implant containing an interface or an interlocked hybrid material with an antioxidant by diffusion, thereby forming an antioxidant-doped medical implant; c) packaging the medical implant; and d) irradiating the packaged medical implant by ionizing radiation, thereby forming an antioxidant-doped cross-linked and sterile medical implant.
- the polymeric material is compression molded to another piece or a medical implant, thereby form an interface or an interlocked hybrid material.
- Another aspect of the invention provides methods to increase the uniformity of an antioxidant in a doped polymeric material by annealing the doped polymeric material below the melting point of the doped polymeric material.
- Another aspect of the invention provides methods to increase the uniformity of an antioxidant in a doped polymeric material by annealing the doped polymeric material above the melting point of the doped polymeric material.
- Figure 1 shows penetration depth of vitamin E diffusion into UHMWPE at room temperature, 100°C, 120°C and 130°C.
- Figure 2 shows the oxidation index profile as a function of depth into one of the representative aged cubes of seven groups studied (Group TCRT, Group RTl, Group RT16, Group TC100C16, Group 100C1, Group TC100C1, and Group 100C16).
- AU cubes were fabricated from an irradiated polyethylene and four of which were doped with vitamin E under various conditions. Thermal control cubes were not treated with vitamin E. Vitamin E doped cubes show less oxidation at the surface and in the bulk of the samples than their corresponding thermal controls.
- Figure 3 shows the diffusion profiles for vitamin E through unirradiated UHMWPE doped at 130°C for 96 hours as a function of subsequent annealing time at 130°C.
- Figure 4 schematically shows examples of sequences of processing UHMWPE and doping at various steps.
- FIG. 5 schematically shows examples of sequences of processing UHMWPE and doping at various steps.
- the present invention provides methods of making oxidation resistant medical implants that comprise medical devices, including permanent and non-permanent devices, and packaging that comprises polymeric material, such as polyethylene.
- the invention pertains to methods of doping consolidated polyethylene, such as UHMWPE, with antioxidants, before, during, or after crosslinking the consolidated polyethylene.
- the doping of consolidated polyethylene can be carried out by diffusion of an antioxidant, for example, ⁇ -tocopherol, such as vitamin E.
- the diffusion of the antioxidant is accelerated by increasing the temperature and/or pressure.
- an antioxidant is delivered in various forms, including in a pure form, for example, as pure vitamin E, or dissolved in a solvent.
- diffusion rate of an antioxidant into the polyethylene is increased by increasing the concentration of the antioxidant solution, for example, a vitamin E solution.
- diffusion rate of an antioxidant into the polyethylene is increased by swelling the consolidated polyethylene in a supercritical fluid, for example, in a supercritical CO 2 , i.e., the temperature being above the supercritical temperature, which is 31.3°C, and the pressure being above the supercritical pressure, which is 73.8 bar.
- a supercritical fluid for example, in a supercritical CO 2 , i.e., the temperature being above the supercritical temperature, which is 31.3°C, and the pressure being above the supercritical pressure, which is 73.8 bar.
- doping subsequent to consolidation avoids the exposure of vitamin E to high temperatures and pressures of consolidation and prevents the discoloration of the polymeric material.
- the invention also decreases the thermal effects on the antioxidant. The thermal effects can reduce the effectiveness of the antioxidant in protecting the polymeric material against oxidation.
- Doping in the consolidated state also allows one to achieve a gradient of antioxidant in consolidated polymeric material.
- an antioxidant for example, vitamin E
- irradiation See for example, Figures 4 and 5
- the doped antioxidant can leach out of the polymeric material used in fabrication of medical implants or medical devices either during storage prior to use or during in vivo service.
- the in vivo duration can be as long as the remaining life of the patient, which is the length of time between implantation of the device and the death of the patient, for example, 1-120 years. If leaching out of the antioxidant is an issue, the irradiation of the medical implant or medical device or irradiation of any portion thereof can be carried out after doping the antioxidant. This can ensure crosslinking of the antioxidant to the host polymer through covalent bonds and thereby prevent loss of antioxidant from the medical implant or the device.
- polymeric material for example, resin powder, flakes, particles, or a mixture thereof, is mixed with an antioxidant and then the mixture is consolidated.
- the consolidated antioxidant doped polymeric material can be machined to use as a component in a medical implant or as a medical device.
- consolidated polymeric material for example, consolidated resin powder, molded sheet, blown films, tubes, balloons, flakes, particles, or a mixture thereof
- an antioxidant for example, vitamin E in the form of ⁇ -Tocopherol
- Consolidated polymeric material for example, consolidated UHMWPE can be soaked in 100% vitamin E or in a solution of ⁇ - Tocopherol in an alcohol, for example, ethanol or isopropanol.
- a solution of ⁇ - Tocopherol, about 50% by weight in ethanol can be used to diffuse in to UHMWPE in contact with a supercritical fluid, such as CO 2 .
- the balloons for example, PeBAX®, Nylon, and PET balloons can be doped with vitamin E and irradiated before, during, or after doping.
- the invention also relates to the following processing steps to fabricate medical devices made out of highly cross-linked polyethylene and containing metallic pieces such as bipolar hip replacements, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral disc systems, and for any implant that contains a surface that cannot be readily sterilized by a gas sterilization method.
- the polyethylene component of a medical implant is in close contact with another material, such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell, wherein the polyethylene, such as resin powder, flakes and particles are directly compression molded to these counter faces.
- a polyethylene tibial insert is manufactured by compression molding of polyethylene resin powder to a tibial tray, to a metallic mesh or back or to a non-metallic mesh or back.
- the mesh is shaped to serve as a fixation interface with the bone, through either bony in-growth or the use of an adhesive, such as polymethylmethacrylate (PMMA) bone cement.
- PMMA polymethylmethacrylate
- acetabular liner for total or unicompartmental knee implants
- patella tray for total or unicompartmental knee implants
- glenoid component ankle, elbow or finger component.
- Another aspect of the invention relates to mechanical interlocking of the molded polyethylene with the other ⁇ iece(s), for example, a metallic or a non-metallic piece, that makes up part of the implant.
- the interface geometry is crucial in that polyethylene assumes the geometry as its consolidated shape.
- Polyethylene has a remarkable property of 'shape memory' due to its very high molecular weight that results in a high density of physical entanglements.
- plastic deformation introduces a permanent shape change, which attains a preferred high entropy shape when melted. This recovery of the original consolidated shape is due to the 'shape memory', which is achieved when the polyethylene is consolidated.
- Balloon catheters often can have intended axial and radial alignment of the polymeric chains.
- Balloon catheters made from polyethylene benefit from the improved wear resistance generated from crosslinking when used with stents.
- the use of catheters and stents coated with drugs precludes the use of ethylene oxide sterilization in some cases; thus ionizing radiation must be used, and the balloon catheter has to be protected from the deleterious effects of free-radical induced oxidation. Annealing of these materials close to the melt transition temperature would result in bulk chain motion and subsequent loss of dimensional tolerances of the part.
- the problems associated with post-irradiation oxidation can be avoided without the need for thermal treatment.
- the balloons for example, PeBAX®, Nylon, and PET balloons can be doped with vitamin E and irradiated before, during, or after doping.
- Another aspect of the invention provides that following the compression moldings of the polyethylene to the counterface with the mechanical interlock, the hybrid component is inadiated using ionizing radiation to a desired dose level, for example, about 25 kGy to about 1000 kGy, preferably between about 25 kGy and about 150 kGy, more preferably between about 50 kGy and about 100 kGy.
- a desired dose level for example, about 25 kGy to about 1000 kGy, preferably between about 25 kGy and about 150 kGy, more preferably between about 50 kGy and about 100 kGy.
- the irradiation step generates residual free radicals and therefore, a melting step is introduced thereafter to quench the residual free radicals. Since the polyethylene is consolidated into the shape of the interface, thereby setting a 'shape memory' of the polymer, the polyethylene does not separate from the counterface.
- methods of crosslinking polyethylene to create a polyethylene-based medical device, wherein the device is immersed in a non-oxidizing medium such as inert gas or inert fluid, wherein the medium is heated to above the melting point of the irradiated polyethylene, for example, UHMWPE (above about 137°C) to eliminate the crystalline matter and to allow the recombination/elimination of the residual free radicals.
- a non-oxidizing medium such as inert gas or inert fluid
- UHMWPE above about 137°C
- Another aspect of the invention provides that following the above steps of free radical elimination, the interface between the metal and the polymer become sterile due to the high irradiation dose level used during inadiation.
- the device surface can be further machined to remove the oxidized surface layer.
- the invention provides that in the case of a post-melting machining of an implant, the melting step can be carried out in the presence of an inert gas.
- Another aspect of the invention includes methods of sterilization of the fabricated device, wherein the device is further sterilized with ethylene oxide, gas plasma, or the other gases, when the interface is sterile but the rest of the component is not.
- the invention discloses packaging of inadiated and antioxidant- doped medical implants or medical devices including compression molded implants or devices, wherein the implants or the devices can be sterilized by ionizing radiation or gas sterilization to obtain sterile and cross-linked medical implants or medical devices.
- Antioxidant refers to what is known in the art as (see, for example, WO 01/80778, US 6,448,315).
- Alpha- and delta-tocopherol propyl, octyl, or dedocyl gallates; lactic, citric, and tartaric acids and their salts; orthophosphates, tocopherol acetate.
- vitamin E Preferably vitamin E.
- Supercritical fluid refers to what is known in the art, for example, supercritical propane, acetylene, carbon dioxide (CO 2 ).
- the critical temperature is that temperature above which a gas cannot be liquefied by pressure alone.
- the pressure under which a substance may exist as a gas in equilibrium with the liquid at the critical temperature is the critical pressure.
- Supercritical fluid condition generally means that the fluid is subjected to such a temperature and such a pressure that a supercritical fluid and thereby a supercritical fluid mixture is obtained, the temperature being above the supercritical temperature, which for CO 2 is 31.3°C, and the pressure being above the supercritical pressure, which for CO 2 is 73.8 bar.
- supercritical condition refers to a condition of a mixture, for example, UHMWPE with an antioxidant, at an elevated temperature and pressure, when a supercritical fluid mixture is formed and then evaporate CO 2 from the mixture, UHMWPE doped with an antioxidant is obtained (see, for example, US 6448315 and WO 02/26464)
- compression molding as refened herein related generally to what is known in the art and specifically relates to high temperature molding polymeric material wherein polymeric material is in any physical state, including powder form, is compressed into a slab form or mold of a medical implant, for example, a tibial insert, an acetabular liner, a glenoid liner, a patella, or an unicompartmental insert, can be machined.
- a medical implant for example, a tibial insert, an acetabular liner, a glenoid liner, a patella, or an unicompartmental insert, can be machined.
- direct compression molding as refened herein related generally to what is known in the art and specifically relates to molding applicable in polyethylene- based devices, for example, medical implants wherein polyethylene in any physical state, including powder form, is compressed to solid support, for example, a metallic back, metallic mesh, or metal surface containing grooves, undercuts, or cutouts.
- the compression molding also includes high temperature compression molding of polyethylene at various states, including resin powder, flakes and particles, to make a component of a medical implant, for example, a tibial insert, an acetabular liner, a glenoid liner, a patella, or an unicompartmental insert.
- mechanically interlocked refers generally to interlocking of polyethylene and the counterface, that are produced by various methods, including compression molding, heat and inadiation, thereby forming an interlocking interface, resulting into a 'shape memory' of the interlocked polyethylene.
- Components of a device having such an interlocking interface can be refened to as a "hybrid material”.
- Medical implants having such a hybrid material contain a substantially sterile interface.
- substantially sterile refers to a condition of an object, for example, an interface or a hybrid material or a medical implant containing interface(s), wherein the interface is sufficiently sterile to be medically acceptable, i.e., will not cause an infection or require revision surgery.
- Metallic mesh refers to a porous metallic surface of various pore sizes, for example, 0.1-3 mm. The porous surface can be obtained through several different methods, for example, sintering of metallic powder with a binder that is subsequently removed to leave behind a porous surface; sintering of short metallic fibers of diameter 0.1-3 mm; or sintering of different size metallic meshes on top of each other to provide an open continuous pore structure.
- Bone cement refers to what is known in the art as an adhesive used in bonding medical devices to bone. Typically, bone cement is made out of polymethylmethacrylate (PMMA).
- PMMA polymethylmethacrylate
- High temperature compression molding refers to the compression molding of polyethylene in any form, for example, resin powder, flakes or particles, to impart new geometry under pressure and temperature. During the high temperature (above the melting point of polyethylene) compression molding, polyethylene is heated to above its melting point, pressurized into a mold of desired shape and allowed to cool down under pressure to maintain a desired shape.
- Shape memory refers to what is known in the art as the property of polyethylene, for example, an UHMWPE, that attains a prefened high entropy shape when melted. The prefened high entropy shape is achieved when the resin powder is consolidated through compression molding.
- substantially no detectable residual free radicals refers to a state of a polyethylene component, wherein enough free radicals are eliminated to avoid oxidative degradation, which can be evaluated by electron spin resonance (ESR).
- detectable residual free radicals refers to the lowest level of free radicals detectable by ESR or more. The lowest level of free radicals detectable with state-of-the-art instruments is about 10 14 spins/gram and thus the term “detectable” refers to a detection limit of 10 14 spins/gram by ESR.
- Ultra-high molecular weight polyethylene refers to linear non-branched chains of ethylene having molecular weights in excess of about 500,000, preferably above about 1,000,000, and more preferably above about 2,000,000. Often the molecular weights can reach about 8,000,000 or more. By initial average molecular weight is meant the average molecular weight of the UHMWPE starting material, prior to any inadiation. See US Patent 5,879,400, PCT/US99/16070, filed on July 16, 1999, and PCT/US97/02220, filed February 11, 1997.
- polymeric materials for example, any polyolefin, including high-density-polyethylene, low-density-polyethylene, linear-low-density-polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or mixtures thereof.
- Polymeric materials as used herein, also applies to polyethylene of various forms, for example, resin powder, flakes, particles, powder, or a mixture thereof, or a consolidated form derived from any of the above.
- Crosslinking Polymeric Material Polymeric Materials, for example, UHMWPE can be cross-linked by a variety of approaches, including those employing cross-linking chemicals (such as peroxides and/or silane) and/or inadiation. Prefened approaches for cross-linking employ inadiation.
- Cross-linked UHMWPE also can be obtained according to the teachings of US Patent 5,879,400, US Patent 6,641,617, and PCT/US97/02220.
- Consolidated polymeric material refers to a solid, consolidated bar stock, solid material machined from stock, or semi-solid form of polymeric material derived from any forms as described herein, for example, resin powder, flakes, particles, or a mixture thereof, that can be consolidated.
- the consolidated polymeric material also can be in the form of a slab, block, solid bar stock, machined component, film, tube, balloon, pre-form, implant, or finished medical device.
- non-permanent device refers to what is known in the art as a device that is intended for implantation in the body for a period of time shorter than several months. Some non-permanent devices could be in the body for a few seconds to several minutes, while other may be implanted for days, weeks, or up to several months.
- Non- permanent devices include catheters, tubing, intravenous tubing, and sutures, for example.
- “Pharmaceutical compound”, as described herein, refers to a drug in the form of a powder, suspension, emulsion, particle, film, cake, or molded form.
- the drug can be freestanding or inco ⁇ orated as a component of a medical device.
- pressure chamber refers to a vessel or a chamber in which the interior pressure can be raised to levels above atmospheric pressure.
- Packaging refers to the container or containers in which a medical device is packaged and/or shipped.
- Packaging can include several levels of materials, including bags, blister packs, heat-shrink packaging, boxes, ampoules, bottles, tubes, trays, or the like or a combination thereof.
- a single component may be shipped in several individual types of package, for example, the component can be placed in a bag, which in turn is placed in a tray, which in turn is placed in a box. The whole assembly can be sterilized and shipped.
- the packaging materials include, but not limited to, vegetable parchments, multi-layer polyethylene, Nylon 6, polyethylene terephthalate (PET), and polyvinyl chloride-vinyl acetate copolymer films, polypropylene, polystyrene, and ethyl ene-vinyl acetate (EVA) copolymers.
- the term "sealing” refers to the process of isolating a chamber or a package from the outside atmosphere by closing an opening in the chamber or the package. Sealing can be accomplished by a variety of means, including application of heat (for example, thermally-sealing), use of adhesive, crimping, cold-molding, stapling, or application of pressure.
- blister packs refers to a packaging comprised of a rigid plastic bowl with a lid or the like that is either peeled or punctured to remove the packaged contents.
- the lid is often made of aluminum, or a gas-permeable membrane such as a Tyvek.
- the blister packs are often blow-molded, a process where the plastic is heated above its deformation temperature, at which point pressurized gas forces the plastic into the required shape.
- heat-shrinkable packaging refers to plastic films, bags, or tubes that have a high degree of orientation in them. Upon application of heat, the packaging shrinks down as the oriented chains refract, often wrapping tightly around the medical device.
- intervertebral disc system refers to an artificial disc that separates the vertebrae in the spine. This system can either be composed of one type of material, or can be a composite structure, for example, cross-linked UHMWPE with metal edges.
- Balloon catheters refers to what is known in the art as a device used to expand the space inside blood vessels or similar. Balloon catheters are usually thin wall polymeric devices with an inflatable tip, and can expand blocked arteries, stents, or can be used to measure blood pressure. Commonly used polymeric balloons include, for example, polyether-block co-polyamide polymer (PeBAX®), Nylon, and polyethylene terephthalate (PET) balloons. Commonly used polymeric material used in the balloons and catheters include, for example, co-polymers of polyether and polyamide (for example, PeBAX®), Polyamides, Polyesters (for example, PET), and ethylene vinyl alcohol (EVA) used in catheter fabrication.
- PeBAX® polyether-block co-polyamide polymer
- PET polyethylene terephthalate
- Commonly used polymeric material used in the balloons and catheters include, for example, co-polymers of polyether and polyamide (for example, PeBAX®), Polyamides, Polyester
- Medical device tubing Materials used in medical device tubing, including an intravenous tubing include, polyvinyl chloride (PVC), polyurethane, polyolefins, and blends or alloys such as thermoplastic elastomers, polyamide/imide, polyester, polycarbonate, or various fluoropolymers.
- PVC polyvinyl chloride
- polyurethane polyurethane
- polyolefins polyolefins
- blends or alloys such as thermoplastic elastomers
- polyamide/imide polyamide/imide
- polyester polycarbonate
- fluoropolymers various fluoropolymers.
- Stent refers to what is known in the art as a metallic or polymeric cage-like device that is used to hold bodily vessels, such as blood vessels, open. Stents are usually introduced into the body in a collapsed state, and are inflated at the desired location in the body with a balloon catheter, where they remain.
- “Melt transition temperature” refers to
- Interface in this invention is defined as the niche in medical devices formed when an implant is in a configuration where a component is in contact with another piece (such as a metallic or a n ⁇ n-metallic component), which forms an interface between the polymer and the metal or another polymeric material.
- a component such as a metallic or a n ⁇ n-metallic component
- interfaces of polymer-polymer or polymer-metal are in medical prosthesis, such as orthopedic joints and bone replacement parts, for example, hip, knee, elbow or ankle replacements.
- the type of radiation preferably ionizing
- a dose of ionizing radiation ranging from about 25 kGy to about 1000 kGy is used.
- the radiation dose can be about 25 kGy, about 50 kGy, about 65 kGy, about 75 kGy, about 100 kGy, about 150, kGy, about 200 kGy, about 300 kGy, about 400 kGy, about 500 kGy, about 600 kGy, about 700 kGy, about 800 kGy, about 900 kGy, or about 1000 kGy, or above 1000 kGy, or any integer thereabout or therebetween.
- the radiation dose can be between about 25 kGy and about 150 kGy or between about 50 kGy and about 100 kGy.
- These types of radiation including gamma and/or electron beam, kills or inactivates bacteria, viruses, or other microbial agents potentially contaminating medical implants, including the interfaces, thereby achieving product sterility.
- the inadiation which may be electron or gamma inadiation, in accordance with the present invention can be carried out in air atmosphere containing oxygen, wherein the oxygen concentration in the atmosphere is at least 1%, 2%, 4%, or up to about 22%, or any integer thereabout or therebetween.
- the inadiation can be carried out in an inert atmosphere, wherein the atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
- the inadiation also can be carried out in a vacuum.
- the inadiation may be carried out in a sensitizing atmosphere.
- a sensitizing atmosphere This may comprise a gaseous substance which is of sufficiently small molecular size to diffuse into the polymer and which, on inadiation, acts as a polyfunctional grafting moiety.
- gases include substituted or unsubstituted polyunsaturated hydrocarbons; for example, acetylenic hydrocarbons such as acetylene; conjugated or unconjugated olefmic hydrocarbons such as butadiene and (meth)acrylate monomers; sulphur monochloride, with chloro-tri-fluoroethylene (CTFE) or acetylene being particularly prefened.
- gaseous is meant herein that the sensitizing atmosphere is in the gas phase, either above or below its critical temperature, at the inadiation temperature.
- the piece forming an interface with polymeric material is, for example, a metal.
- the metal piece in functional relation with polyethylene, according to the present invention can be made of a cobalt chrome alloy, stainless steel, titanium, titanium alloy or nickel cobalt alloy, for example.
- Non-metallic Piece In accordance with the invention, the piece forming an interface with polymeric material is, for example, a non-metal.
- the non-metal piece in functional relation with polyethylene, according to the present invention, can be made of ceramic material, for example.
- inert atmosphere refers to an environment having no more than 1% oxygen and more preferably, an oxidant-free condition that allows free radicals in polymeric materials to form cross links without oxidation during a process of sterilization.
- An inert atmosphere is used to avoid O 2 , which would otherwise oxidize the medical device comprising a polymeric material, such as UHMWPE.
- Inert atmospheric conditions such as nitrogen, argon, helium, or neon are used for sterilizing polymeric medical implants by ionizing radiation.
- Inert atmospheric conditions such as nitrogen, argon, helium, neon, or vacuum are also used for sterilizing interfaces of polymeric-metallic and/or polymeric-polymeric in medical implants by ionizing radiation.
- Inert atmospheric conditions also refers to an inert gas, inert fluid, or inert liquid medium, such as nitrogen gas or silicon oil.
- Anoxic environment refers to an environment containing gas, such as nitrogen, with less than 21%-22% oxygen, preferably with less than 2% oxygen.
- the oxygen concentration in an anoxic environment also can be at least 1%, 2%,
- Vacuum refers to an environment having no appreciable amount of gas, which otherwise would allow free radicals in polymeric materials to form cross links without oxidation during a process of sterilization.
- a vacuum is used to avoid O 2 , which would otherwise oxidize the medical device comprising a polymeric material, such as UHMWPE.
- a vacuum condition can be used for sterilizing polymeric medical implants by ionizing radiation.
- a vacuum condition can be created using a commercially available vacuum pump.
- a vacuum condition also can be used when sterilizing interfaces of polymeric-metallic and/or polymeric-polymeric in medical implants by ionizing radiation.
- Residual free radicals refers to free radicals that are generated when a polymer is exposed to ionizing radiation such as gamma or e-beam inadiation. While some of the free radicals recombine with each other to from crosslinks, some become trapped in crystalline domains. The trapped free radicals are also known as residual free radicals.
- the levels of residual free radicals in the polymer generated during an ionizing radiation is preferably determined using electron spin resonance and treated appropriately to reduce the free radicals.
- One aspect of the present invention discloses a process of sterilization of medical implants containing polymeric material, such as cross-linked
- the process comprises sterilizing the medical implants by ionizing sterilization with gamma or electron beam radiation, for example, at a dose level ranging from 25-70 kGy, or by gas sterilization with ethylene oxide or gas plasma.
- Another aspect of the present invention discloses a process of sterilization of medical implants containing polymeric material, such as cross-linked UHMWPE.
- the process comprises sterilizing the medical implants by ionizing sterilization with gamma or electron beam radiation, for example, at a dose level ranging from 25-200 kGy.
- the dose level of sterilization is higher than standard levels used in inadiation. This is to allow crosslinking or further crosslinking of the medical implants during sterilization.
- the invention discloses a process of sterilizing medical implants containing polymeric material, such as cross-linked UHMWPE, that is in contact with another piece, including polymeric material consolidated by compression molding to another piece, thereby forming an interface and an interlocked hybrid material, comprising sterilizing an interface by ionizing radiation; heating the medium to above the melting point of the inadiated UHMWPE (above about 137°C) to eliminate the crystalline matter and allow for the recombination/elimination of the residual free radicals; and sterilizing the medical implant with a gas, for example, ethylene oxide or gas plasma.
- a gas for example, ethylene oxide or gas plasma.
- One aspect of the present invention discloses a process of increasing the uniformity of the antioxidant following doping in polymeric component of a medical implant during the manufacturing process by heating for a time period depending on the melting temperature of the polymeric material.
- the prefened temperature is about 137°C or less.
- Another aspect of the invention discloses a heating step that can be carried in the air, in an atmosphere, containing oxygen, wherein the oxygen concentration is at least 1%, 2%, 4%, or up to about 22%, or any integer thereabout or therebetween.
- the invention discloses a heating step that can be carried while the implant is in contact with an inert atmosphere, wherein the inert atmosphere contains gas selected from the group consisting of nitrogen, argon, helium, neon, or the like, or a combination thereof.
- the invention discloses a heating step that can be carried while the implant is in contact with a non-oxidizing medium, such as an inert fluid medium, wherein the medium contains no more than about 1% oxygen.
- the invention discloses a heating step that can be carried while the implant is in a vacuum.
- the medical device comprising a polymeric raw material, such as UHMWPE, is generally heated to a temperature of about 137°C or less following the step of doping with the antioxidant.
- the medical device is kept heated in the inert medium until the desired uniformity of the antioxidant is reached.
- low melting point refers to a temperature below the melting point of a polyethylene, for example, UHMWPE.
- low melting point or “below the melt” refers to a temperature less than 145°C, which may vary depending on the melting temperature of the polyethylene, for example, 145°C, 140°C or 135°C, which again depends on the properties of the polyethylene being treated, for example, molecular weight averages and ranges, batch variations, etc.
- the melting temperature is typically measured using a differential scanning calorimeter (DSC) at a heating rate of 10°C per minute.
- DSC differential scanning calorimeter
- the peak melting temperature thus measured is refened to as melting point and occurs, for example, at approximately 137°C for some grades of UHMWPE. It may be desirable to conduct a melting study on the starting polyethylene material in order to determine the melting temperature and to decide upon an inadiation and annealing temperature.
- annealing refers to heating the polymer below its peak melting point.
- Annealing time can be at least 1 minute to several weeks long. In one aspect the annealing time is about 4 hours to about 48 hours, preferably 24 to 48 hours and more preferably about 24 hours. "Annealing temperature” refers to the thermal condition for annealing in accordance with the invention.
- contacted includes physical proximity with or touching such that the sensitizing agent can perform its intended function.
- a polyethylene composition or pre-form is sufficiently contacted such that it is soaked in the sensitizing agent, which ensures that the contact is sufficient.
- Soaking is defined as placing the sample in a specific environment for a sufficient period of time at an appropriate temperature, for example, soaking the sample in a solution of an antioxidant.
- the environment is heated to a temperature ranging from room temperature to a temperature below the melting point of the material.
- the contact period ranges from at least about 1 minute to several weeks and the duration depending on the temperature of the environment.
- non-oxidizing refers to a state of polymeric material having an oxidation index (A. U.) of less than about 0.5 following aging polymeric materials for 5 weeks in air at 80°C oven.
- a non-oxidizing cross-linked polymeric material generally shows an oxidation index (A. U.) of less than about 0.5 after the aging period.
- Doping refers to a process well known in the art (see, for example, US
- doping generally refers to contacting a polymeric material with an antioxidant under certain conditions, as set forth herein, for example, doping UHMWPE with an antioxidant under supercritical conditions.
- consolidated polymeric material can be doped with an antioxidant by soaking the material in a solution of the antioxidant.
- the material can be soaked in 100% antioxidant.
- the material also can be soaked in an antioxidant solution where a carrier solvent can be used to dilute the antioxidant concentration.
- the material can be doped for longer durations, at higher temperatures, at higher pressures, and/or in presence of a supercritical fluid.
- the doping process can involve soaking of a polymeric material, medical implant or device with an antioxidant, such as vitamin E, for about an hour up to several days, preferably for about one hour to 24 hours, more preferably for one hour to 16 hours.
- the antioxidant can be heated to room temperature or up to about 160°C and the doping can be carried out at room temperature or up to about 160°C.
- the antioxidant can be heated to 100°C and the doping is carried out at 100°C.
- the doping step can be followed by a heating step in air or in anoxic environment to improve the uniformity of the antioxidant within the polymeric material, medical implant or device.
- the heating may be carried out above or below or at the peak melting point.
- the medical device is cleaned before packaging and sterilization.
- Vitamin E (AcrosTM 99% D- ⁇ -Tocopherol, Fisher Brand), was used in the experiments described herein, unless otherwise specified. The vitamin E used is very light yellow in color and is a viscous fluid at room temperature. Its melting point is 2-3°C.
- Vitamin E was dissolved in ethanol to create a solution with 10% (w/v) vitamin E concentration.
- the vitamin E-ethanol solution was then dry-blended with GUR 1050 ultra-high molecular weight polyethylene (UHMWPE) resin.
- UHMWPE ultra-high molecular weight polyethylene
- Two batches were prepared: one with vitamin E concentration of 0.1% (w/v) and the other with 0.3% (w/v).
- the vitamin E concentrations were measured after evaporation of ethanol. Both batches were than consolidated on a Carver laboratory bench pressed at a temperature of 230°C in air.
- the consolidated blocks were discolored.
- the 0.1% (w/v) solution appeared dark yellow and the 0.3% (w/v) solution had a brown color.
- the discoloration was uniform throughout the consolidated UHMWPE blocks.
- the discoloration was thought to be the result of the degradation of vitamin E when heated in presence of oxygen.
- Example 2 Discoloration of vitamin E when exposed to heat in air or in vacuum. An experiment was carried out to determine if the vitamin E discoloration is due to exposure to air at elevated temperatures and if the discoloration could be avoided by heating vitamin E under vacuum.
- vitamin E solution As described herein, was placed on a laboratory glass slide. The glass slide was then heated in an air convection oven to 180° C for 1 hour in air. The vitamin E changed its color to a dark brown. The discoloration was most probably due to the degradation of the vitamin E.
- vitamin E was placed on a laboratory glass slide. The glass slide was then heated in a vacuum oven to 180° C for 1 hour under vacuum. In contrast to heating in air, vitamin E showed no discernible color change following heating in vacuum. Therefore, in the absence of air or oxygen, heat treatment of vitamin E results in no discernable color change.
- Vitamin E is dissolved in ethanol to create a solution.
- GUR1050 polyethylene resin is degassed either in vacuum or is kept in an anoxic environment to substantially remove the dissolved oxygen.
- the vitamin E-ethanol solution is then dry-blended with GUR1050 polyethylene resin.
- Two batches are prepared, one with degassed GUR1050 and the other with the as-received GUR1050 polyethylene resin.
- the dry-blended mixtures are then separately consolidated on a Carver laboratory bench press. Consolidation can be carried out in an anoxic environment to minimize the discoloration of the consolidated stock.
- Vitamin E ( ⁇ -tocopherol) was mixed with GUR 1050 UHMWPE powder, in two concentrations, for example, 0.1% and 0.3% weight/volume, and consolidated.
- the consolidation of UHMWPE into blocks was achieved by compression molding.
- One additional consolidation was carried out without vitamin E additive, to use as a control.
- the three consolidated blocks were machined into halves and one half of each was packaged in vacuum and inadiated to 100 kGy with gamma radiation (Steris, Northborough, MA).
- Cylindrical pins 9 mm in diameter and 13 mm in length, were cut out of the inadiated blocks.
- the pins were first subjected to accelerated aging at 80°C for 5 weeks in air and subsequently tested on a bi-directional pin-on-disk (POD).
- the POD test was run for a total of 2 million cycles with gravimetric assessment of wear at every 0.5 million cycles.
- the test was run at a frequency of 2Hz with bovine serum, as a lubricant.
- the typical wear rate of UHMWPE with no radiation history and no vitamin E is around 8.0 milligram per million cycles.
- the wear rates for the 100 kGy inadiated vitamin E added pins were 2.10 ⁇ 0.17 and 5.01 ⁇ 0.76 milligram per million cycles for the 0.1% and 0.3% vitamin E concentrations, respectively.
- the reduction in wear resistance is less with higher vitamin E content.
- Example 5 Diffusion of vitamin E into consolidated polyethylene.
- a drop of vitamin E was placed on a machined surface of consolidated GUR1050 UHMWPE in air. In six hours, the vitamin E drop was no longer visible on that machined surface, indicating that it had diffused into the polyethylene.
- Example 6 Diffusion of vitamin E into irradiated polyethylene.
- Compression molded GUR1050 UHMWPE (Pe ⁇ las, Lanchashire, UK) was inadiated using gamma radiation at a dose level of 100 kGy.
- the other five pins served as control samples.
- the two groups of pins were left in air at room temperature for 16 hours. They were then placed in a convection oven at 80°C in air for accelerated aging. The aged pins were removed from the oven after five weeks to determine the extent of oxidation.
- the pins were first cut in half along the axis of the cylinder.
- Oxidation index was calculated by normalizing the area under the carbonyl vibration (1740 cm “1 ) to that under the methylene vibration at 1370 cm “1 , after subtracting the conesponding baselines.
- the oxidation levels were substantially reduced by the application of vitamin E onto the surface of inadiated polyethylene. Therefore, this method can be used to improve the long-term oxidative stability of inadiated polyethylene, for example, in medical devices containing polymeric material.
- Example 7 Diffusion of vitamin E into polyethylene followed by irradiation.
- the inadiated cubes were removed from the packages and placed in an oven at 80°C in the air for accelerated aging.
- the aged cubes were removed from the oven after five weeks to determine the extent of oxidation.
- the cubes were first cut into halves. One of the cut surfaces was then microtomed (150-200 micrometer) and a BioRad UMA 500 infra-red microscope was used to collect infra-red spectrum as a function of distance away from one of the edges.
- Oxidation index was calculated by normalizing the area under the carbonyl vibration (1740 cm “1 ) to that under the methylene vibration at 1370 cm "1 , after subtracting the conesponding baselines.
- oxidation levels were substantially reduced by the application of vitamin E onto the surface of polyethylene prior to inadiation in air or anoxic environment. Therefore, this method can be used to improve the long-term oxidative stability of polyethylene that may subsequently be inadiated to sterilization and/or crosslinking polymeric material, for example, medical devices containing polymeric material.
- Example 8 Fabrication of a highly cross-linked medical device.
- a tibial knee insert is machined from compression molded GUR1050 UHMWPE.
- the insert is then soaked in 100% vitamin E or a solution of vitamin E.
- the diffusion of vitamin E into the insert may be accelerated by increasing temperature and/or pressure, which can be carried out either in air or inert or anoxic environment.
- the insert is packaged either in air or inert or anoxic environment.
- the packaged insert is then inadiated to 100 kGy dose. The inadiation serves two pu ⁇ oses: (1) crosslinks the polyethylene and improves wear resistance and (2) sterilizes the implant.
- the polyethylene implant can be any polyethylene medical device including those with abutting interfaces to other materials, such as metals.
- An example of this is non-modular, metal-backed, polyethylene components used in total joint arthroplasty.
- Example 9 Diffusion of vitamin E in polyethylene.
- the samples were rinsed with ethanol to remove excess ⁇ -tocopherol from surfaces of the cubes.
- the extent of ⁇ -tocopherol diffusion into polyethylene was quantified by using infrared microscopy and measuring a characteristic absorbance of ⁇ -tocopherol as a function of depth away from a free surface.
- the cubes that were doped with ⁇ -tocopherol were machined to halves and sectioned (about 100 ⁇ m thin sections) using an LKB Sledge Microtome (Sweden).
- the thin sections were analyzed using a BioRad UMA 500 infrared microscope (Natick, MA). Infrared spectra were collected with an aperture size of 50x 50 ⁇ m as a function of depth away from one of the edges that coincided with the free surface of the cube.
- the spectra were analyzed by quantifying the absorbance, which is typically generated by vitamin E, namely the absorbance between 1226 and 1275 cm ""1 wave numbers.
- the area under the absorbance was integrated and normalized to the area under the reference absorbance peak, located between 1850 and 1985 cm "1 .
- the integration of both the vitamin E absorbance and the reference absorbance excluded the respective baselines.
- the normalized value is refened to as vitamin E index.
- Figure 1 demonstrates the diffusion profiles of polyethylene cubes that were doped at four different temperatures (25°C, 100°C, 120°C and 130°C). Depth of ⁇ - tocopherol diffusion in polyethylene increased with temperature from 400 ⁇ m at 25 °C to 3 mm at 130°C under ambient pressure.
- the diffusion depth and uniformity of the antioxidant, in this example of vitamin E, can be varied by varying the doping temperature.
- Example 10 Artificial aging of UHMWPE with and without vitamin E.
- Microtomed sections (200 ⁇ m each) were then analyzed with a BioRad UMA500 infra-red microscope. Infra-red spectra were collected, as a function of depth away from the edge of the microtomed section, which conesponded to the vitamin E exposed cylindrical base. The spectra were analyzed by quantifying the carbonyl absorbance between 1680 and 1780 cm "1 wave numbers. The area under the absorbance was integrated and normalized to the area under the reference absorbance peak located between 1330 and 1390 cm "1 . The integration of both the carbonyl absorbance and the reference absorbance excluded the respective baselines. The normalized value is refened to as oxidation index.
- the clean UHMWPE pin sample showed about six times higher oxidation index than that of the vitamin E treated pin.
- Example 11 Improved oxidation resistance with vitamin E doping.
- Compression molded GUR 1050 UHMWPE blocks (Pe ⁇ las Ltd., Lancashire, UK) (3 inches in diamater) were gamma-inadiated in vacuum to a dose of 111-kGy (Steris Isomedix, Northborough, MA). Inadiated blocks were machined into half-cubes of dimensions about 2cm x 2cm x 1cm.
- the half-cubes of the Group RTl were soaked at room temperature for one hour.
- the half-cubes of the Group RTl 6 were soaked at room temperature for 16 hour.
- the half-cubes of the Group lOOCl were soaked at 100°C for one hour.
- the half-cubes of the Group 100C16 were soaked at 100°C for 16 hours. There were a total 3 half-cubes in each group.
- three groups of thermal controls were prepared with three half-cubes in each group.
- Group TCRT consisted of half-cubes that were machined from one of the inadiated blocks.
- Group TC100C1 consisted of half-cubes that were heated to 100°C for one hour in air.
- Group TC100C16 consisted of half-cubes that were heated to 100°C for 16 hours in air.
- the soaked and thermal control half-cubes described above were then cleaned in a dishwasher. Cleaning was performed by a portable Kenmore dishwasher (Sears Inc, Hoffman Estates, IL) on normal cycle with rinse and heat drying. During cleaning, all half-cube test samples were placed in a cylindrical non-elastic polyethylene mesh of 2 inches in diameter and closed at the ends. This ensured that the samples did not move around, but the cleaning medium could get through. ElectrasolTM (Reckitt Benckiser Inc., Berkshire, UK) was used as cleaning agent.
- the samples were subject to accelerated aging to determine the effect of tocopherol doping under different conditions on the oxidative stability of the inadiated UHMWPE. Accelerated aging was performed by placing the samples in an oven at 80°C in air for five weeks.
- the half-cubes were cut in halves and microtomed to prepare a 200 ⁇ m thin section pe ⁇ endicular to one of the 2cm x 2cm surfaces.
- Microtomed sections 200 ⁇ m each) were analyzed with a BioRad UMA500 infra-red microscope. Infra-red spectra were collected, as a function of depth away from the edge of the microtomed section, which conesponded to the surface that was soaked in tocopherol and also exposed to air during aging. The spectra were analyzed by quantifying the carbonyl absorbance between 1680 and 1780 cm "1 wave numbers.
- the area under the absorbance was integrated and no ⁇ nalized to the area under the reference absorbance peak located between 1330 and 1390 cm “1 .
- the integration of both the carbonyl absorbance and the reference absorbance excluded the respective baselines.
- the normalized value is refened to as oxidation index.
- Thermal control for 111-kGy inadiated, cleaned and aged samples for UHMWPE doped with tocopherol at 100°C for 1 hour showed higher levels of oxidation than the conesponding tocopherol doped test samples (Group 100C1).
- thermal control Group TC100C16 for 111-kGy inadiated, cleaned and aged samples for UHMWPE doped with tocopherol at 100°C for 16 hours showed higher levels of oxidation than the tocopherol doped test samples (Group 100C16).
- the oxidation levels of the thermal controls and test samples did not show significant difference between a soak time of 1 hour and 16 hours.
- the oxidation levels for doped samples at 100°C were less than those doped at room temperature.
- Figure 2 shows the oxidation index profile as a function of depth into one of the representative aged cubes of each group studied (Group TCRT, Group RTl, Group RT16, Group TC100C16, Group 100C1, Group TC100C1, and Group 100C16).
- Example 12 Ionizing sterilization of balloon catheters.
- Example 13 Improved oxidation resistance of packaging material.
- Packaging made from polyethylene films is soaked in vitamin E at room temperature and kept under pressure for 16 hours.
- the packaging is then sterilized by ionizing radiation at doses 25-40 kGy.
- the packaging is protected from oxidation- induced embrittlement, which can affect both the mechanical integrity and the gas barrier properties of the packaging.
- Example 14 Irradiation and doping of UHMWPE.
- Cubes (20 mm to a side) were machined from three different bar stocks made out of GUR1050 UHMWPE that are treated as follows: (1) gamma inadiated to 65 kGy, (2) gamma inadiated to 100 kGy, and (3) uninadiated.
- the cubes were than doped by soaking in vitamin E (DL- ⁇ -tocopherol) for 16 hours at room temperature.
- Two groups of cubes, one machined from the 65 kGy and the other from the 100 kGy inadiated stocks, were packaged following doping with vitamin E and inadiated again with gamma inadiation for sterilization at a dose level of 25-40 kGy.
- One additional group of cubes, machined from uninadiated stock was packaged following doping with vitamin E and inadiated again with gamma inadiation for crosslinking and sterilization at a dose level of 125-140 kGy.
- Example 15 The Pin-On-Disk (POD) wear behavior of irradiated and vitamin E doped UHMWPE before and after aging.
- POD Pin-On-Disk
- Consolidated GUR 1050 UHMWPE bar stocks were gamma inadiated at 65 kGy and 100 kGy. Cylindrical pins (9 mm in diameter and 13 mm in length) samples for POD wear testing were machined from the inadiated bar stocks. The samples were doped with vitamin E ( ⁇ -Tocopherol) for 16 hours at room temperature in air. Following doping, the samples were further gamma sterilized at a dose of 27 kGy. These two groups are refened to as ⁇ -T-92 and ⁇ -T-127 with a total radiation doses of 92 kGy and 127 kGy, respectively.
- the pins were subjected to 200,000 cycles of POD testing to reach a steady state wear rate independent of diffusion or asperities on the surface. Thereafter, three pins of each. group were tested for a total of 2 million cycles. The wear rate was calculated as the linear regression of wear vs. number of cycles from 0.2 to 2 million cycles. The wear rates of doped and aged cross-linked polyethylenes are shown in Table 2.
- Table 2 The wear rate of doped and aged cross-linked polyethylene.
- the wear behavior of the doped samples were comparable before and after aging, indicating that the presence of an antioxidant inco ⁇ orated by diffusion can protect the inadiated polyethylene from oxidation and thus prevent an increase in wear after aging.
- the wear rate of a 100-kGy inadiated UHMWPE is around 1 milligrams per million-cycle (Muratoglu et al, Biomaterials, 20(16): 1463 -1470, 1999). Aging of an 105-kGy inadiated UHMWPE can increase its wear rate to above 20 milligram per cycle (Muratoglu et al. Clinical Orthopaedics & Related Research, 417:253-262, 2003).
- Example 16 Oxidation stabilization of polyether-block co-polyamide balloons.
- Balloons fabricated from polyether-block co-polyamide polymer (PeBAX®) are sterilized with either gamma or electron beam after packaging.
- PeBAX® polyether-block co-polyamide polymer
- quenching of the free radicals is imperative to ensure an extended shelf life (for example, a three-year shelf life).
- These materials cannot be heat-treated following inadiation, given that the highly aligned polymer chains relax when exposed to elevated temperatures, resulting in radial and axial shrinkage.
- Polyether-block co-polyamide balloons are soaked in vitamin E, or in a solution of vitamin E and a solvent such as an alcohol.
- the balloons are packaged, and then subjected to sterilization doses ranging from 25-70 kGy.
- the higher radiation dose results from double sterilization doses. Sterilization can occur either in air or in a low oxygen atmosphere.
- the vitamin E minimizes the oxidative behavior of residual free radicals introduced during the sterilization process and also can reduce undesired crosslinking.
- Example 17 Oxidation stabilization of Nylon balloons. Balloons fabricated from Nylon polymer are sterilized with either gamma or electron beam after packaging. As there is concern about oxidative embrittlement of these materials due to free radical generation, quenching of the free radicals is imperative to ensure a three year shelf life. These materials cannot be heat-treated following inadiation, given that the highly aligned polymer chains relax when exposed to elevated temperatures, resulting in radial and axial shrinkage. Nylon balloons are soaked in vitamin E, or in a solution of vitamin E and a solvent such as an alcohol. The balloons are packaged, and then subjected to sterilization doses ranging from 25-70 kGy. The higher radiation dose results from double sterilization doses. Sterilization can occur either in air or in a low oxygen atmosphere. The vitamin E minimizes the oxidative behavior of residual free radicals introduced during the sterilization process and also can reduce undesired crosslinking.
- Example 18 Oxidation stabilization of Polyethylene terephthalate balloons.
- PET polyethylene terephthalate
- a solvent such as an alcohol
- Sterilization can occur either in air or in a low oxygen atmosphere.
- the vitamin E minimizes the oxidative behavior of residual free radicals introduced during the sterilization process and also can reduce undesired crosslinking.
- Example 19 Oxidation stabilization of Multi-component balloons.
- Multi-component balloons fabricated from a combination of polymers including polyethylene, PET, polyether-block co-polyamide, polyvinyl acetate, and nylon, are sterilized with either gamma or electron beam after packaging.
- a combination of polymers including polyethylene, PET, polyether-block co-polyamide, polyvinyl acetate, and nylon.
- quenching of the free radicals is imperative to ensure an extended shelf life (for example, a three-year shelf life).
- These materials cannot be heat-treated following inadiation, given that the highly aligned polymer chains relax when exposed to elevated temperatures, resulting in radial and axial shrinkage.
- These multi-component balloons are soaked in vitamin E, or in a solution of vitamin E and a solvent such as an alcohol.
- the balloons are packaged, and then subjected to sterilization doses ranging from 25-70 kGy.
- the higher radiation dose results from double sterilization doses. Sterilization can occur either in air or in a low oxygen atmosphere.
- the vitamin E minimizes the oxidative behavior of residual free radicals introduced during the sterilization process, and also can reduce undesired crosslinking.
- Example 20 Sterilization of Polypropylene medical devices.
- Polypropylene is widely used in the medical industry to produce syringes, vials, and numerous other devices, often through injection molding. Polypropylene is known to exhibit oxidative degradation when it is subjected to ionizing sterilization with gamma or electron beam or gas sterilization with ethylene oxide or gas plasma.
- Polypropylene syringes are soaked in vitamin E, or in a solution of vitamin E and a solvent such as an alcohol.
- the syringes are packaged, and then subjected to sterilization doses ranging from 25-70 kGy.
- the higher radiation dose results from double sterilization doses. Sterilization can occur either in air or in a low oxygen atmosphere.
- the vitamin E will minimizes the oxidative behavior of residual free radicals introduced during the sterilization process, and could also reduce undesired crosslinking.
- Example 21 Sterilization of flexible polyvinyl chloride tubing.
- PVC Polyvinyl chloride
- tubing While previously sterilized with ethylene oxide, more manufacturers are using gamma or electron beam to sterilize. Upon exposure to ionizing radiation, these material often darken and yellow, which is believed to be due to oxidation (Medical Plastics and Biomaterials Magazine, March, 1996, Douglas W. Luther and Leonard A. Linsky). Yellowing is reduced when antioxidants are compounded into the PVC with a mechanical mixer or extruder.
- PVC tubing is soaked in vitamin E, or in a solution of vitamin E and a solvent such as an alcohol.
- the tubing is then subjected to sterilization doses ranging from 25-70 kGy.
- the higher radiation dose results from double sterilization doses. Sterilization can occur either in air or in a low oxygen atmosphere.
- the vitamin E minimizes the oxidative behavior of residual free radicals introduced during the sterilization process, and results in color-stabilized PVC components, as well as improved shelf life.
- Example 22 Annealing after doping. Post-doping annealing can be used to achieve a more uniform antioxidant distribution. Uninadiated UHMWPE cubes were doped at 130°C for 96 hours by soaking in undiluted ⁇ -tocopherol. One cube was machined in halves and microtomed. The microtomed sections were analyzed using infra-red microscopy, as described above in Example 9, to measure the vitamin E index as a function of depth away from one of the surfaces that was free during doping. Subsequent to doping, other doped cubes were annealed at 130°C for increasing periods of time.
- the doped and annealed cubes were also analyzed using the infrared microscope to determine the changes on the vitamin E index profile as a function of annealing time.
- Figure 3 shows the diffusion profiles measured in the doped and also doped and annealed cubes. In the sample that has not been annealed, the surface concentration was much higher than that for the bulk, but the sample that had been annealed for 100 hours at the same temperature showed a nearly uniform profile. Therefore, annealing after doping can be used to increase the uniformity of the antioxidant distribution throughout the host polymer.
- the temperature and time of annealing can be tailored by carrying out a parametric analysis as described herein.
- UHMWPE can be doped with antioxidants at various stages, for example, as schematically shown in Figures 4 and 5.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Electromagnetism (AREA)
- Toxicology (AREA)
- Thermal Sciences (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Prostheses (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2004206826A AU2004206826B8 (en) | 2003-01-16 | 2004-01-15 | Methods for making oxidation resistant polymeric material |
CA 2513538 CA2513538C (en) | 2003-01-16 | 2004-01-15 | Methods for making oxidation resistant polymeric material |
EP04702484.9A EP1596755B1 (en) | 2003-01-16 | 2004-01-15 | Methods for making oxidation resistant polymeric material |
JP2006500941A JP5122126B2 (en) | 2003-01-16 | 2004-01-15 | Method for producing oxidation-resistant polymer material |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44038903P | 2003-01-16 | 2003-01-16 | |
US60/440,389 | 2003-01-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2004064618A2 true WO2004064618A2 (en) | 2004-08-05 |
WO2004064618A3 WO2004064618A3 (en) | 2005-05-12 |
WO2004064618B1 WO2004064618B1 (en) | 2005-07-14 |
Family
ID=32771812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/000857 WO2004064618A2 (en) | 2003-01-16 | 2004-01-15 | Methods for making oxidation resistant polymeric material |
Country Status (6)
Country | Link |
---|---|
US (14) | US7431874B2 (en) |
EP (3) | EP1596755B1 (en) |
JP (3) | JP5122126B2 (en) |
AU (2) | AU2004206826B8 (en) |
CA (1) | CA2513538C (en) |
WO (1) | WO2004064618A2 (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1518563A1 (en) * | 2003-09-29 | 2005-03-30 | Medtronic Vascular, Inc. | Method of sterilizing a balloon, e.g. of a balloon catheter, with ionizing radiation |
JP2007500773A (en) * | 2003-05-19 | 2007-01-18 | レデラー,クラウス | Cross-linked ultra high molecular weight polyethylene (UHMW-PE) |
EP1750614A1 (en) * | 2004-05-11 | 2007-02-14 | The Massachusetts General Hospital | Methods for making oxidation resistant polymeric material |
WO2007019874A1 (en) * | 2005-08-18 | 2007-02-22 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US7214764B2 (en) | 2003-06-30 | 2007-05-08 | Depuy Products, Inc. | Free radical quench process for irradiated ultrahigh molecular weight polyethylene |
WO2007106582A2 (en) * | 2006-03-15 | 2007-09-20 | Promethean Lifesciences, Inc. | Preparation and storage of stable, biologically active materials |
US7335697B2 (en) | 2004-12-23 | 2008-02-26 | Depuy Products, Inc. | Polymer composition comprising cross-linked polyethylene and methods for making the same |
EP1919983A2 (en) * | 2005-08-22 | 2008-05-14 | The General Hospital Corporation doing business as Massachusetts General Hospital | Oxidation resistant homogenized polymeric material |
US7431874B2 (en) | 2003-01-16 | 2008-10-07 | Massachusetts General Hospital | Methods for making oxidation resistant polymeric material |
WO2008124825A2 (en) * | 2007-04-10 | 2008-10-16 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
DE102008047009A1 (en) | 2008-07-11 | 2010-01-21 | Mathys Ag Bettlach | Joint socket with physiological load transfer |
US7683133B2 (en) | 2006-08-25 | 2010-03-23 | Depuy Products, Inc. | Bearing material of medical implant and methods for making it |
EP2208739A1 (en) * | 2005-08-22 | 2010-07-21 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Highly crystalline polyethylene |
US7812098B2 (en) | 2006-03-31 | 2010-10-12 | Depuy Products, Inc. | Bearing material of medical implant having reduced wear rate and method for reducing wear rate |
WO2010136173A1 (en) * | 2009-05-26 | 2010-12-02 | Aesculap Ag | Polyolefin doped with a stabilizer |
JP2012143575A (en) * | 2012-03-06 | 2012-08-02 | Zimmer Gmbh | Ultra high molecular weight polyethylene article and method of forming the same |
US8343230B2 (en) | 2005-09-22 | 2013-01-01 | Depuy Products, Inc. | Orthopaedic bearing material |
US8426486B2 (en) | 2004-02-03 | 2013-04-23 | The General Hospital Corporation | Highly crystalline cross-linked oxidation-resistant polyethylene |
US8546460B2 (en) | 2007-09-04 | 2013-10-01 | Smith & Nephew, Inc. | Ultra high molecular weight polyethylene for bearing surfaces |
US8586667B2 (en) | 2008-05-13 | 2013-11-19 | Smith & Nephew Orthopaedics Ag | Oxidation resistant highly-crosslinked UHMWPE |
AU2012203503B2 (en) * | 2005-08-18 | 2014-01-30 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US8664290B2 (en) | 2007-04-10 | 2014-03-04 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
AU2013200780B2 (en) * | 2007-04-10 | 2015-01-22 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
JP2015097814A (en) * | 2015-01-30 | 2015-05-28 | ジンマー ゲーエムベーハー | Ultra high molecular weight polyethylene product and method for forming ultra high molecular weight polyethylene product |
AU2014201581B2 (en) * | 2005-08-18 | 2015-11-26 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
WO2016090084A1 (en) * | 2014-12-03 | 2016-06-09 | Zimmer, Inc. | Antioxidant-infused ultra high molecular weight polyethylene |
WO2016153925A1 (en) * | 2015-03-25 | 2016-09-29 | Zimmer, Inc. | Melt-stabilized ultra high molecular weight polyethylene |
WO2016169536A1 (en) | 2015-04-21 | 2016-10-27 | Ustav Makromolekularni Chemie Av Cr, V.V.I. | Composition for stabilization of polyethylene, polyethylene, method of preparation thereof, polyethylene implants |
US9708467B2 (en) | 2013-10-01 | 2017-07-18 | Zimmer, Inc. | Polymer compositions comprising one or more protected antioxidants |
US9718241B2 (en) | 2008-01-30 | 2017-08-01 | Zimmer, Inc. | Method of manufacturing an acetabular component |
US9745462B2 (en) | 2008-11-20 | 2017-08-29 | Zimmer Gmbh | Polyethylene materials |
US10184031B2 (en) | 2014-03-12 | 2019-01-22 | Zimmer, Inc. | Melt-stabilized ultra high molecular weight polyethylene and method of making the same |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2047823A1 (en) | 2000-04-27 | 2009-04-15 | Orthopaedic Hospital | Oxidation-restistant and wear-resistant polyethylenes for human joint replacements and methods for making them |
WO2004066876A1 (en) * | 2003-01-27 | 2004-08-12 | Medtronic Vascular Connaught | Improved packaging for stent delivery systems |
SE526945C2 (en) * | 2003-04-02 | 2005-11-22 | Amcor Flexibles Europe As | Materials for packaging purposes containing vitamin E to prevent oxidation, as well as a packaging thereof and process for the preparation of the material |
EP1686932B1 (en) | 2003-06-27 | 2010-01-06 | ABS Corporation | System for ankle arthroplasty |
DE102004040939A1 (en) * | 2004-08-24 | 2006-03-02 | Hte Ag The High Throughput Experimentation Company | Apparatus and method for compacting particles |
US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
WO2006036970A2 (en) * | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Method of thickening a coating using a drug |
US8263102B2 (en) | 2004-09-28 | 2012-09-11 | Atrium Medical Corporation | Drug delivery coating for use with a stent |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801913B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Barrier layer |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US7344672B2 (en) * | 2004-10-07 | 2008-03-18 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US8262976B2 (en) * | 2004-10-07 | 2012-09-11 | Biomet Manufacturing Corp. | Solid state deformation processing of crosslinked high molecular weight polymeric materials |
US7462318B2 (en) | 2004-10-07 | 2008-12-09 | Biomet Manufacturing Corp. | Crosslinked polymeric material with enhanced strength and process for manufacturing |
US7803310B2 (en) * | 2005-06-14 | 2010-09-28 | Omni Life Science, Inc. | Crosslinked polyethylene article |
AU2013200385B2 (en) * | 2005-08-22 | 2014-07-10 | The General Hospital Corporation | Highly crystalline polyethylene |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US20070077268A1 (en) * | 2005-09-30 | 2007-04-05 | Depuy Products, Inc. | Hydrophobic carrier modified implants for beneficial agent delivery |
CA2626030A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
US7615075B2 (en) * | 2005-11-04 | 2009-11-10 | Rush University Medical Center | Plastic implant impregnated with a degradation protector |
US9440003B2 (en) * | 2005-11-04 | 2016-09-13 | Boston Scientific Scimed, Inc. | Medical devices having particle-containing regions with diamond-like coatings |
US20100197822A1 (en) * | 2005-12-01 | 2010-08-05 | Brennan Anthony B | Reduced creep high molecular weight polyethylene and methods for forming the same |
US8425614B2 (en) * | 2006-03-20 | 2013-04-23 | Biomet Manufacturing Corp. | Modular center pegged glenoid |
AU2007201213A1 (en) * | 2006-04-06 | 2007-10-25 | Tyco Healthcare Group Lp | Yarns containing thermoplastic elastomer copolymer and polyolefin filaments |
US20090035572A1 (en) * | 2006-04-06 | 2009-02-05 | Tyco Healthcare Group Lp | Yarns containing thermoplastic elastomer copolymer and polyolefin filaments |
US20100124583A1 (en) | 2008-04-30 | 2010-05-20 | Xyleco, Inc. | Processing biomass |
WO2008057328A2 (en) | 2006-11-06 | 2008-05-15 | Atrium Medical Corporation | Tissue separating device with reinforced support for anchoring mechanisms |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
JP5535650B2 (en) * | 2007-01-25 | 2014-07-02 | ザ・ジェネラル・ホスピタル・コーポレイション | Method for producing oxidation-resistant crosslinked polymeric material |
AU2013205248B2 (en) * | 2007-01-25 | 2015-01-15 | Cambridge Polymer Group, Inc. | Methods for making oxidation-resistant cross-linked polymeric materials |
WO2008101073A2 (en) * | 2007-02-14 | 2008-08-21 | Brigham And Women's Hospital, Inc. | Crosslinked polymers |
AU2013200723B2 (en) * | 2007-03-02 | 2014-06-19 | Cambridge Polymer Group, Inc. | Cross-linking of antioxidant-containing polymers |
US9441081B2 (en) * | 2007-03-02 | 2016-09-13 | The General Hospital Corp. | Cross-linking of antioxidant-containing polymers |
CA2681475A1 (en) * | 2007-03-20 | 2008-09-25 | Smith & Nephew Orthopaedics Ag | Oxidation resistant highly-crosslinked uhmwpe |
US9308300B2 (en) * | 2007-04-19 | 2016-04-12 | Smith & Nephew, Inc. | Prosthetic implants |
US8641959B2 (en) | 2007-07-27 | 2014-02-04 | Biomet Manufacturing, Llc | Antioxidant doping of crosslinked polymers to form non-eluting bearing components |
WO2009045658A1 (en) * | 2007-10-05 | 2009-04-09 | The Brigham And Women's Hospital, Inc. | Crosslinked polymers and methods of making the same |
US8212087B2 (en) * | 2008-04-30 | 2012-07-03 | Xyleco, Inc. | Processing biomass |
US8236535B2 (en) | 2008-04-30 | 2012-08-07 | Xyleco, Inc. | Processing biomass |
RU2649370C2 (en) | 2008-04-30 | 2018-04-02 | Ксилеко, Инк. | Biomass treatment |
US7867358B2 (en) | 2008-04-30 | 2011-01-11 | Xyleco, Inc. | Paper products and methods and systems for manufacturing such products |
CN103937839A (en) | 2008-06-18 | 2014-07-23 | 希乐克公司 | Treatment of materials with ion beams |
JP5311457B2 (en) * | 2008-06-20 | 2013-10-09 | ナカシマメディカル株式会社 | Method of molding sliding member for artificial joint and sliding member for artificial joint molded by this method |
GB0812890D0 (en) * | 2008-07-11 | 2008-08-20 | Smith & Nephew Orthopaedics Ag | Compositions and methods of making compositions |
US20100022678A1 (en) * | 2008-07-24 | 2010-01-28 | Zimmer, Inc. | Reduction of free radicals in crosslinked polyethylene by infrared heating |
US8133436B2 (en) * | 2008-08-05 | 2012-03-13 | Howmedica Osteonics Corp. | Polyethylene cross-linked with an anthocyanin |
RU2011110394A (en) * | 2008-08-20 | 2012-09-27 | Е.И.Дюпон де Немур энд Компани (US) | METHOD FOR ESTIMATING WEAR RESISTANCE AT HIGH TEMPERATURE |
DE102008053793A1 (en) * | 2008-10-21 | 2010-04-22 | Aesculap Ag | Synthetic polymer material, useful for producing medical articles e.g. catheters and trocar, comprises amino acids and/or peptides having anti-oxidative effect |
US8933145B2 (en) | 2009-02-20 | 2015-01-13 | The General Hospital Corporation | High temperature melting |
DE102009001145A1 (en) * | 2009-02-25 | 2010-09-09 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Method for curing and surface functionalization of molded parts |
EP2414440B1 (en) * | 2009-03-31 | 2019-03-27 | Zimmer, Inc. | Surface modification of ultrahigh molecular weight polyethylene |
US20110111456A1 (en) | 2009-04-03 | 2011-05-12 | Xyleco, Inc. | Processing biomass |
BRPI1013940A2 (en) | 2009-05-04 | 2016-04-05 | Smith & Nephew Inc | synergistic effects of mixing multiple additives in uhmwpe |
WO2010135526A2 (en) * | 2009-05-20 | 2010-11-25 | The General Hospital Corporation | Methods of preventing oxidation |
JP4806717B2 (en) * | 2009-06-25 | 2011-11-02 | 株式会社沖データ | Image processing system |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
CA2771384A1 (en) | 2009-08-19 | 2011-02-24 | Smith & Nephew, Inc. | Porous implant structures |
PL2488918T3 (en) | 2009-10-14 | 2018-11-30 | Xyleco, Inc. | Marking paper products |
US8246687B2 (en) * | 2009-11-18 | 2012-08-21 | Biomet Manufacturing Corp. | Shoulder prosthetic |
GB0922339D0 (en) | 2009-12-21 | 2010-02-03 | Mcminn Derek J W | Acetabular cup prothesis and introducer thereof |
US8303666B2 (en) | 2010-01-28 | 2012-11-06 | Biomet Manufacturing Corp. | Modular Proximal Interphalangeal Joint |
US8444699B2 (en) | 2010-02-18 | 2013-05-21 | Biomet Manufacturing Corp. | Method and apparatus for augmenting bone defects |
JP5765797B2 (en) * | 2010-02-24 | 2015-08-19 | ナカシマメディカル株式会社 | Ultra high molecular weight polyethylene molded product |
US8399535B2 (en) | 2010-06-10 | 2013-03-19 | Zimmer, Inc. | Polymer [[s]] compositions including an antioxidant |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US20120046383A1 (en) * | 2010-08-19 | 2012-02-23 | Terumo Kabushiki Kaisha | Silicone rubber composition |
US9676896B2 (en) * | 2010-09-09 | 2017-06-13 | Innovative Urethane, Llc | Sugar-based polyurethanes, methods for their preparation, and methods of use thereof |
US8747479B2 (en) | 2011-04-26 | 2014-06-10 | Michael A. McShane | Tibial component |
AU2012282660B2 (en) * | 2011-07-11 | 2017-07-27 | The Children's Hospital Of Philadelphia | Oxidation resistant bioprosthetic tissues and preparation thereof |
EP2731522B1 (en) | 2011-07-13 | 2017-11-15 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Devices for knee joint replacement with anterior cruciate ligament substitution |
US8506638B2 (en) | 2011-07-13 | 2013-08-13 | Biomets Manufacturing, LLC | Shoulder prosthesis |
US20130018476A1 (en) | 2011-07-13 | 2013-01-17 | Biomet Manufacturing Corp. | Shoulder prosthesis |
EP2758096A4 (en) | 2011-09-21 | 2015-07-01 | Bayer Medical Care Inc | Continuous multi-fluid delivery system and method |
US20140188240A1 (en) | 2012-02-07 | 2014-07-03 | Conformis, Inc. | Methods and devices related to patient-adapted hip joint implants |
JP6061670B2 (en) * | 2012-12-27 | 2017-01-18 | 京セラメディカル株式会社 | Method for manufacturing sliding member for artificial joint and sliding member for artificial joint |
WO2013180228A1 (en) * | 2012-05-31 | 2013-12-05 | 京セラメディカル株式会社 | Sliding material and method for producing same |
JP5936566B2 (en) * | 2013-02-28 | 2016-06-22 | 京セラメディカル株式会社 | Manufacturing method of sliding member |
JP6192362B2 (en) * | 2012-05-31 | 2017-09-06 | 京セラ株式会社 | Sliding member and manufacturing method thereof |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
WO2014025636A1 (en) * | 2012-08-06 | 2014-02-13 | The General Hospital Corporation | Spatial control of additives by high temperature |
CN102824232B (en) * | 2012-08-28 | 2015-07-22 | 中国科学院宁波材料技术与工程研究所 | Anti-oxidation artificial joint prosthesis and preparation method thereof |
JP6004225B2 (en) * | 2012-09-04 | 2016-10-05 | 帝人ナカシマメディカル株式会社 | Manufacturing method of molded products |
CN105263447A (en) | 2012-09-27 | 2016-01-20 | 马萨诸塞总医院运营总医院公司 | Femoral heads, mobile inserts, acetabular components, and modular junctions for orthopedic implants and methods of using femoral heads, mobile inserts, acetabular components, and modular junctions for orthopedic implants |
JP6215834B2 (en) * | 2012-10-11 | 2017-10-18 | 帝人ナカシマメディカル株式会社 | Manufacturing method of molded products |
US9949837B2 (en) | 2013-03-07 | 2018-04-24 | Howmedica Osteonics Corp. | Partially porous bone implant keel |
US20140272383A1 (en) * | 2013-03-14 | 2014-09-18 | The General Hospital Corporation | Highly crystalline polyethylene |
US9586370B2 (en) | 2013-08-15 | 2017-03-07 | Biomet Manufacturing, Llc | Method for making ultra high molecular weight polyethylene |
CA2927056A1 (en) | 2013-10-17 | 2015-04-23 | The General Hospital Corporation | Peroxide cross-linking and high temperature melting |
RU2699811C1 (en) * | 2014-03-07 | 2019-09-11 | Айконлаб Инк. | Multipurpose implant with specified surface structure for soft tissue reconstruction |
US20150368375A1 (en) | 2014-06-24 | 2015-12-24 | Biomet Manufacturing, Llc | Methods For Making Crosslinked Ultra High Molecular Weight Polyethylene |
SG11201700017SA (en) | 2014-07-08 | 2017-01-27 | Xyleco Inc | Marking plastic-based products |
KR102528289B1 (en) | 2015-01-09 | 2023-05-03 | 바이엘 헬쓰케어 엘엘씨 | Multiple fluid delivery systems with multiple use disposable sets and features thereof |
DE102015012939A1 (en) * | 2015-10-01 | 2017-04-06 | Kocher-Plastik Maschinenbau Gmbh | Method for reducing the microbiological burden on container products |
US10298099B2 (en) * | 2016-02-29 | 2019-05-21 | Dana Automotive Systems Group, Llc | Method of sensor misalignment learning for motor speed estimation |
AU2017261160A1 (en) | 2016-05-02 | 2018-11-22 | The General Hospital Corporation | Implant surfaces for pain control |
EP3497152B1 (en) * | 2016-08-11 | 2023-06-07 | SABIC Global Technologies B.V. | Polypropylene composition |
WO2019046243A2 (en) | 2017-08-29 | 2019-03-07 | The General Hospital Corporation | Uv-initiated reactions in polymeric materials |
US10512495B2 (en) * | 2017-12-28 | 2019-12-24 | Industrial Technology Research Institute | Method for fabricating medical device and applications thereof |
KR102157283B1 (en) * | 2018-04-20 | 2020-09-17 | 주식회사 무한에너지 | Buoyant body using eco-friendly materials and manufacturing method thereof |
EP3784148A4 (en) | 2018-04-24 | 2022-01-19 | Paragon 28, Inc. | Implants and methods of use and assembly |
US11376128B2 (en) | 2018-12-31 | 2022-07-05 | Depuy Ireland Unlimited Company | Acetabular orthopaedic prosthesis and method |
US11103367B2 (en) | 2019-02-15 | 2021-08-31 | Encore Medical, L.P. | Acetabular liner |
US11291549B2 (en) | 2019-12-11 | 2022-04-05 | Depuy Ireland Unlimited Company | Ceramic acetabular shell liners with augments |
US11628066B2 (en) | 2019-12-11 | 2023-04-18 | Depuy Ireland Unlimited Company | Ceramic acetabular shell liner with a metal ring having a lead-in surface |
US11970600B2 (en) | 2021-03-31 | 2024-04-30 | The General Hospital Corporation | Di-cumyl peroxide crosslinking of UHMWPE |
US12042389B2 (en) | 2021-04-30 | 2024-07-23 | Depuy Ireland Unlimited Company | Apparatus and method for installing an acetabular liner on an acetabular cup |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827904A (en) | 1996-09-27 | 1998-10-27 | Hahn; David | Medical implant composition |
US5879400A (en) | 1996-02-13 | 1999-03-09 | Massachusetts Institute Of Technology | Melt-irradiated ultra high molecular weight polyethylene prosthetic devices |
EP0995450A1 (en) | 1998-10-21 | 2000-04-26 | Sulzer Orthopädie AG | UHMW-polyethylene for implants |
WO2000049079A1 (en) | 1999-02-17 | 2000-08-24 | Bone Support Ab | A method for the preparation of uhmwpe doped with an antioxidant and an implant made thereof |
WO2001080778A1 (en) | 2000-04-27 | 2001-11-01 | The Orthopaedic Hospital | Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them |
WO2002026464A1 (en) | 2000-09-29 | 2002-04-04 | Depuy Orthopaedics, Inc. | Supercritical fluid treatment of irradiated polyethylene |
US6641617B1 (en) | 1996-02-13 | 2003-11-04 | The General Hospital Corp. | Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method |
US9702220B2 (en) | 2012-02-21 | 2017-07-11 | Onesubsea Ip Uk Limited | Well tree hub and interface for retrievable processing modules |
US9916070B1 (en) | 2008-08-28 | 2018-03-13 | Google Llc | Architectures and methods for creating and representing time-dependent imagery |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314420A (en) * | 1961-10-23 | 1967-04-18 | Haeger Potteries Inc | Prosthetic parts and methods of making the same |
CS221403B1 (en) | 1981-12-23 | 1983-04-29 | Bretislav Dolezel | Method of hygienic faultless stabilization of the polyolefine against thermooxidation and photooxidation degradation |
JPS60157835A (en) * | 1984-01-26 | 1985-08-19 | Japan Styrene Paper Co Ltd | Manufacture and its device of crosslinked polyolefin resin foam |
US4596728A (en) * | 1985-02-01 | 1986-06-24 | The Johns Hopkins University | Low temperature heat shrinkable polymer material |
BR8907794A (en) | 1988-12-02 | 1991-08-27 | Du Pont | ULTRA HIGH LINEAR MOLECULAR WEIGHT POLYETHYLENE, ARTICLES AND PRODUCTION PROCESSES |
CA2031406C (en) | 1989-12-21 | 2002-05-28 | Paolo Galli | Graft copolymers of polyolefins and a method of producing same |
EP0517418B1 (en) | 1991-06-03 | 2003-11-26 | Takara Bio Inc. | A method for cloning of a gene for Pol I type DNA polymerase |
US5470354A (en) * | 1991-11-12 | 1995-11-28 | Biomet Inc. | Force sensing apparatus and method for orthopaedic joint reconstruction |
US5466530A (en) * | 1993-01-21 | 1995-11-14 | England; Garry L. | Biocompatible components fabricated from a substantially consolidated stock of material |
US5414049A (en) | 1993-06-01 | 1995-05-09 | Howmedica Inc. | Non-oxidizing polymeric medical implant |
DE4433201A1 (en) * | 1994-09-17 | 1996-03-21 | Merck Patent Gmbh | Process for the production of active ingredient-containing bone cements |
US5577368A (en) * | 1995-04-03 | 1996-11-26 | Johnson & Johnson Professional, Inc. | Method for improving wear resistance of polymeric bioimplantable components |
US5585434A (en) | 1995-05-31 | 1996-12-17 | Montell North America Inc. | Blends of polyolefin graft copolymers and polycarbonate |
US8865788B2 (en) * | 1996-02-13 | 2014-10-21 | The General Hospital Corporation | Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices |
US5753182A (en) * | 1996-02-14 | 1998-05-19 | Biomet, Inc. | Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components |
US6087553A (en) * | 1996-02-26 | 2000-07-11 | Implex Corporation | Implantable metallic open-celled lattice/polyethylene composite material and devices |
CA2170561C (en) * | 1996-02-28 | 2001-01-30 | Raymond Wood | Gas, fire and earthquake detector |
EP2319546A1 (en) * | 1996-07-09 | 2011-05-11 | Orthopaedic Hospital | Crosslinking of polytheylene for low wear using radiation and thermal treatments |
US6228900B1 (en) * | 1996-07-09 | 2001-05-08 | The Orthopaedic Hospital And University Of Southern California | Crosslinking of polyethylene for low wear using radiation and thermal treatments |
US6017975A (en) | 1996-10-02 | 2000-01-25 | Saum; Kenneth Ashley | Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance |
WO1998016258A1 (en) * | 1996-10-15 | 1998-04-23 | The Orthopaedic Hospital | Wear resistant surface-gradient cross-linked polyethylene |
JP4315261B2 (en) * | 1998-02-25 | 2009-08-19 | ナカシマメディカル株式会社 | Sliding member for artificial joint and manufacturing method |
US6692679B1 (en) | 1998-06-10 | 2004-02-17 | Depuy Orthopaedics, Inc. | Cross-linked molded plastic bearings |
EP0995449A1 (en) | 1998-10-21 | 2000-04-26 | Sulzer Orthopädie AG | UHMW-polyethylene for implants |
US6355215B1 (en) | 1999-03-10 | 2002-03-12 | Implex Corp. | Wear-resistant olefinic medical implant and thermal treatment container therefor |
US6184265B1 (en) | 1999-07-29 | 2001-02-06 | Depuy Orthopaedics, Inc. | Low temperature pressure stabilization of implant component |
US6620198B2 (en) * | 1999-10-07 | 2003-09-16 | Exactech, Inc. | Composite bearing inserts for total knee joints |
JP3437952B2 (en) | 2000-08-18 | 2003-08-18 | 日本ポリオレフィン株式会社 | Laminated body and method for producing the same |
US6818172B2 (en) | 2000-09-29 | 2004-11-16 | Depuy Products, Inc. | Oriented, cross-linked UHMWPE molding for orthopaedic applications |
US6547828B2 (en) * | 2001-02-23 | 2003-04-15 | Smith & Nephew, Inc. | Cross-linked ultra-high molecular weight polyethylene for medical implant use |
US6821470B2 (en) * | 2001-06-29 | 2004-11-23 | Depuy Products, Inc. | Joint prosthesis molding method |
AU2004206826B8 (en) | 2003-01-16 | 2009-03-26 | Cambridge Polymer Group, Inc. | Methods for making oxidation resistant polymeric material |
JP5248107B2 (en) | 2004-05-11 | 2013-07-31 | ザ、ジェネラル、ホスピタル、コーポレイション | Method for producing oxidation-resistant polymeric material |
US7329465B2 (en) * | 2004-10-29 | 2008-02-12 | 3M Innovative Properties Company | Optical films incorporating cyclic olefin copolymers |
AU2005335669B2 (en) * | 2005-08-18 | 2012-03-15 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US20070111009A1 (en) * | 2005-11-16 | 2007-05-17 | Morris Barry A | Multilayer composite structure with epoxide containing adhesive layer |
WO2008124825A2 (en) * | 2007-04-10 | 2008-10-16 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
WO2009045658A1 (en) * | 2007-10-05 | 2009-04-09 | The Brigham And Women's Hospital, Inc. | Crosslinked polymers and methods of making the same |
AR077956A1 (en) | 2009-09-14 | 2011-10-05 | Bayer Cropscience Ag | COMBINATIONS OF ACTIVE COMPOUNDS |
KR101920314B1 (en) | 2011-10-31 | 2019-02-08 | 엘지이노텍 주식회사 | Camara module |
-
2004
- 2004-01-15 AU AU2004206826A patent/AU2004206826B8/en not_active Ceased
- 2004-01-15 EP EP04702484.9A patent/EP1596755B1/en not_active Expired - Lifetime
- 2004-01-15 EP EP20130180485 patent/EP2671538A1/en not_active Ceased
- 2004-01-15 EP EP20130180487 patent/EP2664299A1/en not_active Ceased
- 2004-01-15 WO PCT/US2004/000857 patent/WO2004064618A2/en active Application Filing
- 2004-01-15 JP JP2006500941A patent/JP5122126B2/en not_active Expired - Fee Related
- 2004-01-15 CA CA 2513538 patent/CA2513538C/en not_active Expired - Fee Related
- 2004-01-15 US US10/757,551 patent/US7431874B2/en not_active Expired - Fee Related
-
2005
- 2005-04-13 US US11/104,582 patent/US20050194723A1/en not_active Abandoned
- 2005-04-13 US US11/104,580 patent/US7498365B2/en not_active Expired - Fee Related
-
2006
- 2006-11-29 US US11/564,594 patent/US7906064B2/en active Active
-
2007
- 2007-11-30 US US11/948,393 patent/US7790095B2/en not_active Expired - Lifetime
-
2008
- 2008-10-30 AU AU2008240320A patent/AU2008240320B2/en not_active Ceased
-
2009
- 2009-05-12 US US12/464,235 patent/US8530057B2/en not_active Expired - Lifetime
-
2010
- 2010-01-20 US US12/690,185 patent/US8038927B2/en not_active Expired - Fee Related
- 2010-09-15 US US12/882,481 patent/US8728379B2/en not_active Expired - Fee Related
-
2011
- 2011-01-10 US US12/987,399 patent/US8968628B2/en not_active Expired - Lifetime
-
2012
- 2012-01-30 JP JP2012016768A patent/JP5758317B2/en not_active Expired - Fee Related
- 2012-01-30 JP JP2012016767A patent/JP5758316B2/en not_active Expired - Fee Related
- 2012-04-23 US US13/453,535 patent/US8888859B2/en not_active Expired - Fee Related
-
2013
- 2013-03-14 US US13/826,930 patent/US9370878B2/en active Active
-
2014
- 2014-05-27 US US14/287,723 patent/US9688004B2/en not_active Expired - Fee Related
-
2017
- 2017-05-16 US US15/596,318 patent/US9943993B2/en not_active Expired - Fee Related
-
2018
- 2018-03-07 US US15/914,176 patent/US10821632B2/en not_active Expired - Lifetime
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5879400A (en) | 1996-02-13 | 1999-03-09 | Massachusetts Institute Of Technology | Melt-irradiated ultra high molecular weight polyethylene prosthetic devices |
US6641617B1 (en) | 1996-02-13 | 2003-11-04 | The General Hospital Corp. | Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method |
US5827904A (en) | 1996-09-27 | 1998-10-27 | Hahn; David | Medical implant composition |
EP0995450A1 (en) | 1998-10-21 | 2000-04-26 | Sulzer Orthopädie AG | UHMW-polyethylene for implants |
WO2000049079A1 (en) | 1999-02-17 | 2000-08-24 | Bone Support Ab | A method for the preparation of uhmwpe doped with an antioxidant and an implant made thereof |
US6448315B1 (en) | 1999-02-17 | 2002-09-10 | Bone Support Ab | Method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof |
WO2001080778A1 (en) | 2000-04-27 | 2001-11-01 | The Orthopaedic Hospital | Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them |
WO2002026464A1 (en) | 2000-09-29 | 2002-04-04 | Depuy Orthopaedics, Inc. | Supercritical fluid treatment of irradiated polyethylene |
US9916070B1 (en) | 2008-08-28 | 2018-03-13 | Google Llc | Architectures and methods for creating and representing time-dependent imagery |
US9702220B2 (en) | 2012-02-21 | 2017-07-11 | Onesubsea Ip Uk Limited | Well tree hub and interface for retrievable processing modules |
Non-Patent Citations (5)
Title |
---|
MARCH, 1996; DOUGLAS W. LUTHER; LEONARD A. LINSKY, MEDICAL PLASTICS AND BIOMATERIALS MAGAZINE |
MORI ET AL.: "Hand-out at the 47th Annual Meeting", ORTHOPAEDIC RES SOC, 28 February 2001 (2001-02-28), pages 1017 |
MURATOGLU ET AL., BIOMATERIALS, vol. 20, no. 16, 1999, pages 1463 - 1470 |
MURATOGLU ET AL., CLINICAL ORTHOPAEDICS & RELATED RESEARCH, vol. 417, 2003, pages 253 - 262 |
See also references of EP1596755A4 |
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7790095B2 (en) | 2003-01-16 | 2010-09-07 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US9370878B2 (en) | 2003-01-16 | 2016-06-21 | The General Hospital Corp. | Methods for making oxidation resistant polymeric material |
US7498365B2 (en) | 2003-01-16 | 2009-03-03 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US9688004B2 (en) | 2003-01-16 | 2017-06-27 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US9943993B2 (en) | 2003-01-16 | 2018-04-17 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US8728379B2 (en) | 2003-01-16 | 2014-05-20 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US8888859B2 (en) | 2003-01-16 | 2014-11-18 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US7906064B2 (en) | 2003-01-16 | 2011-03-15 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US8968628B2 (en) | 2003-01-16 | 2015-03-03 | The General Hospital Corp. | Methods for making oxidation resistant polymeric material |
US7431874B2 (en) | 2003-01-16 | 2008-10-07 | Massachusetts General Hospital | Methods for making oxidation resistant polymeric material |
US10821632B2 (en) | 2003-01-16 | 2020-11-03 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US8530057B2 (en) | 2003-01-16 | 2013-09-10 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
JP2007500773A (en) * | 2003-05-19 | 2007-01-18 | レデラー,クラウス | Cross-linked ultra high molecular weight polyethylene (UHMW-PE) |
US8227531B2 (en) | 2003-05-19 | 2012-07-24 | Klaus Lederer | Crosslinked, ultrahigh molecular weight polyethylene (UHMW-PE) |
JP4751830B2 (en) * | 2003-05-19 | 2011-08-17 | レデラー,クラウス | Cross-linked ultra high molecular weight polyethylene (UHMW-PE) |
US7214764B2 (en) | 2003-06-30 | 2007-05-08 | Depuy Products, Inc. | Free radical quench process for irradiated ultrahigh molecular weight polyethylene |
US7695674B2 (en) | 2003-09-29 | 2010-04-13 | Medtronic Vascular, Inc. | Method of sterilizing balloon with ionizing radiation |
EP1518563A1 (en) * | 2003-09-29 | 2005-03-30 | Medtronic Vascular, Inc. | Method of sterilizing a balloon, e.g. of a balloon catheter, with ionizing radiation |
EP3111895A1 (en) * | 2004-02-03 | 2017-01-04 | The General Hospital Corporation | Highly crystalline cross-linked oxidation-resistant polyethylene |
US9168683B2 (en) | 2004-02-03 | 2015-10-27 | The General Hospital Corporation | Highly crystalline cross-linked oxidation-resistant polyethylene |
US8426486B2 (en) | 2004-02-03 | 2013-04-23 | The General Hospital Corporation | Highly crystalline cross-linked oxidation-resistant polyethylene |
US8318065B2 (en) | 2004-05-11 | 2012-11-27 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US9561306B2 (en) | 2004-05-11 | 2017-02-07 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
US7833452B2 (en) | 2004-05-11 | 2010-11-16 | The General Hospital Corporation | Method for making oxidation resistant polymeric material |
US8865043B2 (en) | 2004-05-11 | 2014-10-21 | The General Hospital Corporation | Methods for making oxidation resistant polymeric material |
EP1750614A1 (en) * | 2004-05-11 | 2007-02-14 | The Massachusetts General Hospital | Methods for making oxidation resistant polymeric material |
EP1750614A4 (en) * | 2004-05-11 | 2011-10-26 | Gen Hospital Corp | Methods for making oxidation resistant polymeric material |
US7335697B2 (en) | 2004-12-23 | 2008-02-26 | Depuy Products, Inc. | Polymer composition comprising cross-linked polyethylene and methods for making the same |
US11001680B2 (en) | 2005-08-18 | 2021-05-11 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
EP2172229A1 (en) * | 2005-08-18 | 2010-04-07 | Zimmer GmbH | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
EP2792373A1 (en) * | 2005-08-18 | 2014-10-22 | Zimmer GmbH | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
EP2277561A1 (en) * | 2005-08-18 | 2011-01-26 | Zimmer GmbH | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
WO2007019874A1 (en) * | 2005-08-18 | 2007-02-22 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US8673202B2 (en) | 2005-08-18 | 2014-03-18 | Zimmer, Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
AU2012203503B2 (en) * | 2005-08-18 | 2014-01-30 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
AU2005335669B2 (en) * | 2005-08-18 | 2012-03-15 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
US11015030B2 (en) | 2005-08-18 | 2021-05-25 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
EP2277560A1 (en) * | 2005-08-18 | 2011-01-26 | Zimmer GmbH | Ultra high molecular weight polyethylene articles and methods od forming ultra high molecular weight polyethylene articles |
US7846376B2 (en) | 2005-08-18 | 2010-12-07 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
EP3170515A1 (en) * | 2005-08-18 | 2017-05-24 | Zimmer GmbH | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
AU2014201581B2 (en) * | 2005-08-18 | 2015-11-26 | Zimmer Gmbh | Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles |
JP2009504283A (en) * | 2005-08-18 | 2009-02-05 | ツィンマー・ゲーエムベーハー | Ultra high molecular weight polyethylene article and method of forming ultra high molecular weight polyethylene article |
EP2441781A1 (en) * | 2005-08-22 | 2012-04-18 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Highly crystalline polyethylene |
JP2013151693A (en) * | 2005-08-22 | 2013-08-08 | General Hospital Corp | Oxidation resistant homogenized polymeric material |
AU2006283601B2 (en) * | 2005-08-22 | 2011-10-20 | The General Hospital Corporation Dba Massachusetts General Hospital | Oxidation resistant homogenized polymeric material |
EP1919983A4 (en) * | 2005-08-22 | 2009-05-13 | Gen Hospital Corp | Oxidation resistant homogenized polymeric material |
US9273189B2 (en) | 2005-08-22 | 2016-03-01 | The General Hospital Corporation | Highly crystalline polyethylene |
US8420000B2 (en) | 2005-08-22 | 2013-04-16 | The General Hospital Corporation | Highly crystalline polyethylene |
US8425815B2 (en) | 2005-08-22 | 2013-04-23 | The General Hospital Corporation | Highly crystalline polyethylene |
JP2009504899A (en) * | 2005-08-22 | 2009-02-05 | ザ ジェネラル ホスピタル コーポレイション ディー ビー エイ マサチューセッツ ジェネラル ホスピタル | Oxidation resistant homogenized polymeric material |
US8461225B2 (en) | 2005-08-22 | 2013-06-11 | The General Hospital Corporation | Oxidation resistant homogenized polymeric material |
US8889757B2 (en) | 2005-08-22 | 2014-11-18 | The General Hospital Corporation | Oxidation resistant homogenized polymeric material |
AU2006283596B2 (en) * | 2005-08-22 | 2012-10-11 | The General Hospital Corporation | Highly crystalline polyethylene |
EP2208739A1 (en) * | 2005-08-22 | 2010-07-21 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Highly crystalline polyethylene |
EP2441780A1 (en) * | 2005-08-22 | 2012-04-18 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Highly Crystalline Polyethylene |
EP2420527A1 (en) * | 2005-08-22 | 2012-02-22 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Oxidation resistant homogenized polymeric material |
EP1919983A2 (en) * | 2005-08-22 | 2008-05-14 | The General Hospital Corporation doing business as Massachusetts General Hospital | Oxidation resistant homogenized polymeric material |
EP2420526A1 (en) * | 2005-08-22 | 2012-02-22 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Oxidation resistant homogenized polymeric material |
EP2420528A1 (en) * | 2005-08-22 | 2012-02-22 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Oxidation resistant homogenized polymeric material |
US8343230B2 (en) | 2005-09-22 | 2013-01-01 | Depuy Products, Inc. | Orthopaedic bearing material |
WO2007106582A2 (en) * | 2006-03-15 | 2007-09-20 | Promethean Lifesciences, Inc. | Preparation and storage of stable, biologically active materials |
WO2007106582A3 (en) * | 2006-03-15 | 2007-11-22 | Promethean Lifesciences Inc | Preparation and storage of stable, biologically active materials |
US7812098B2 (en) | 2006-03-31 | 2010-10-12 | Depuy Products, Inc. | Bearing material of medical implant having reduced wear rate and method for reducing wear rate |
US7683133B2 (en) | 2006-08-25 | 2010-03-23 | Depuy Products, Inc. | Bearing material of medical implant and methods for making it |
US10556998B2 (en) | 2007-04-10 | 2020-02-11 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications |
EP2486948A1 (en) * | 2007-04-10 | 2012-08-15 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
WO2008124825A2 (en) * | 2007-04-10 | 2008-10-16 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
WO2008124825A3 (en) * | 2007-04-10 | 2009-12-17 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
EP2564882A1 (en) * | 2007-04-10 | 2013-03-06 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9265545B2 (en) | 2007-04-10 | 2016-02-23 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
EP2578248A1 (en) * | 2007-04-10 | 2013-04-10 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
AU2013200780B2 (en) * | 2007-04-10 | 2015-01-22 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9926432B2 (en) | 2007-04-10 | 2018-03-27 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US8669299B2 (en) | 2007-04-10 | 2014-03-11 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US9277949B2 (en) | 2007-04-10 | 2016-03-08 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications |
US9822224B2 (en) | 2007-04-10 | 2017-11-21 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications |
AU2008236996B2 (en) * | 2007-04-10 | 2012-11-08 | Zimmer, Inc. | An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US8664290B2 (en) | 2007-04-10 | 2014-03-04 | Zimmer, Inc. | Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications |
US8546460B2 (en) | 2007-09-04 | 2013-10-01 | Smith & Nephew, Inc. | Ultra high molecular weight polyethylene for bearing surfaces |
US9718241B2 (en) | 2008-01-30 | 2017-08-01 | Zimmer, Inc. | Method of manufacturing an acetabular component |
US8586667B2 (en) | 2008-05-13 | 2013-11-19 | Smith & Nephew Orthopaedics Ag | Oxidation resistant highly-crosslinked UHMWPE |
DE102008047009B4 (en) | 2008-07-11 | 2020-08-06 | Mathys Ag Bettlach | Joint socket with physiological load transfer |
DE102008047009A1 (en) | 2008-07-11 | 2010-01-21 | Mathys Ag Bettlach | Joint socket with physiological load transfer |
US9745462B2 (en) | 2008-11-20 | 2017-08-29 | Zimmer Gmbh | Polyethylene materials |
WO2010136173A1 (en) * | 2009-05-26 | 2010-12-02 | Aesculap Ag | Polyolefin doped with a stabilizer |
JP2012143575A (en) * | 2012-03-06 | 2012-08-02 | Zimmer Gmbh | Ultra high molecular weight polyethylene article and method of forming the same |
US9708467B2 (en) | 2013-10-01 | 2017-07-18 | Zimmer, Inc. | Polymer compositions comprising one or more protected antioxidants |
US10184031B2 (en) | 2014-03-12 | 2019-01-22 | Zimmer, Inc. | Melt-stabilized ultra high molecular weight polyethylene and method of making the same |
CN107207741A (en) * | 2014-12-03 | 2017-09-26 | 捷迈有限公司 | Inject the ultra-high molecular weight polyethylene of antioxidant |
US10265891B2 (en) | 2014-12-03 | 2019-04-23 | Zimmer, Inc. | Antioxidant-infused ultra high molecular weight polyethylene |
WO2016090084A1 (en) * | 2014-12-03 | 2016-06-09 | Zimmer, Inc. | Antioxidant-infused ultra high molecular weight polyethylene |
CN107207741B (en) * | 2014-12-03 | 2021-05-11 | 捷迈有限公司 | Antioxidant-infused ultra-high molecular weight polyethylene |
JP2015097814A (en) * | 2015-01-30 | 2015-05-28 | ジンマー ゲーエムベーハー | Ultra high molecular weight polyethylene product and method for forming ultra high molecular weight polyethylene product |
WO2016153925A1 (en) * | 2015-03-25 | 2016-09-29 | Zimmer, Inc. | Melt-stabilized ultra high molecular weight polyethylene |
WO2016169536A1 (en) | 2015-04-21 | 2016-10-27 | Ustav Makromolekularni Chemie Av Cr, V.V.I. | Composition for stabilization of polyethylene, polyethylene, method of preparation thereof, polyethylene implants |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10821632B2 (en) | Methods for making oxidation resistant polymeric material | |
EP1750614B1 (en) | Methods for making oxidation resistant polymeric material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
B | Later publication of amended claims |
Effective date: 20050525 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2513538 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004206826 Country of ref document: AU Ref document number: 2006500941 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004206826 Country of ref document: AU |
|
REEP | Request for entry into the european phase |
Ref document number: 2004702484 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004702484 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004702484 Country of ref document: EP |